{
    "id": "dbpedia_3065_0",
    "rank": 5,
    "data": {
        "url": "https://pubs.rsc.org/en/content/articlehtml/2015/cs/c5cs00048c",
        "read_more_link": "",
        "language": "en",
        "title": "Developments and recent advancements in the field of endogenous amino acid selective bond forming reactions for bioconjugation",
        "top_image": "",
        "meta_img": "",
        "images": [
            "https://pubs.rsc.org/content/NewImages/royal-society-of-chemistry-logo.png",
            "https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_square.svg",
            "https://pubs.rsc.org/content/newimages/open_access_blue.png",
            "https://pubs.rsc.org/content/newimages/CCBY.svg",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-p1.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-p2.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f1.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f2.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f3.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f4.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f5.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f6.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f7.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f8.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f9.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f10.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f11.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f12.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f13.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f14.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f15.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f16.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f17.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f18.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f19.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f20.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f21.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f22.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f23.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f24.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f25.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f26.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f27.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f28.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f29.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f30.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f31.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f32.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f33.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f34.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f35.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f36.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f37.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f38.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f39.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f40.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f41.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f42.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f43.gif",
            "https://www.rsc.org/images/entities/char_2009.gif",
            "https://www.rsc.org/images/entities/char_2009.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f44.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f45.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f46.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f47.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f48.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f49.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f50.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f51.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f52.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f53.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f54.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f55.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f56.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f57.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f58.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f59.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f60.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f61.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f62.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f63.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f64.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f65.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f66.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f67.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f68.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f69.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f70.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f71.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f72.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f73.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f74.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f75.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f76.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f77.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f78.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f79.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-u1.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-u2.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-u3.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-u4.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f80.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f81.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f82.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f83.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f84.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-u5.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-u6.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-u7.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-u8.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-u9.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-u10.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-u11.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-u12.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-u13.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-u14.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-u15.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-u16.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-u17.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-u18.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-u19.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-u20.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-u21.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-u22.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-u23.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-u24.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-u25.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-u26.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-u27.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-u28.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f85.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f86.gif",
            "https://www.rsc.org/images/entities/char_2009.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f87.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f88.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f89.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f90.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f91.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f92.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f93.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f94.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f95.gif",
            "https://pubs.rsc.org/image/article/2015/CS/c5cs00048c/c5cs00048c-f96.gif"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [
            "Oleksandr Koniev",
            "Alain Wagner"
        ],
        "publish_date": "2015-07-20T00:00:00",
        "summary": "",
        "meta_description": "",
        "meta_lang": "en",
        "meta_favicon": "",
        "meta_site_name": "",
        "canonical_link": "https://pubs.rsc.org/en/content/articlehtml/2015/cs/c5cs00048c",
        "text": "Open Access Article\n\nThis Open Access Article is licensed under a\n\nCreative Commons Attribution 3.0 Unported Licence\n\nDOI: 10.1039/C5CS00048C (Review Article) Chem. Soc. Rev., 2015, 44, 5495-5551\n\nDevelopments and recent advancements in the field of endogenous amino acid selective bond forming reactions for bioconjugation\n\nOleksandr Koniev ab and Alain Wagner *a\n\naLaboratory of Functional Chemo-Systems (UMR 7199), Labex Medalis, University of Strasbourg, 74 Route du Rhin, 67401 Illkirch-Graffenstaden, France. E-mail: alwag@unistra.fr\n\nbSyndivia SAS, 4 rue Boussingault, 67000 Strasbourg, France\n\nReceived 19th January 2015\n\nFirst published on 22nd May 2015\n\nAbstract\n\nBioconjugation methodologies have proven to play a central enabling role in the recent development of biotherapeutics and chemical biology approaches. Recent endeavours in these fields shed light on unprecedented chemical challenges to attain bioselectivity, biocompatibility, and biostability required by modern applications. In this review the current developments in various techniques of selective bond forming reactions of proteins and peptides were highlighted. The utility of each endogenous amino acid-selective conjugation methodology in the fields of biology and protein science has been surveyed with emphasis on the most relevant among reported transformations; selectivity and practical use have been discussed.\n\nIntroduction\n\nBioconjugation is a set of techniques allowing site-specific creation of a covalent link between a biomolecule and an exogenous moiety that endow it with desirable properties. This novel hybrid having the combined properties of its individual components can serve, for instance, as a more stable and efficient therapeutic,1–4 an assembly for studying proteins in the biological context,5–11 a new protein-based material,12–17 a microarray,18,19 a biological material,20–24 a tool for immobilisation,25 and for elucidation of the structure26,27 of proteins.\n\nA large number of reactions exist to modify proteins.28 However, site-specific conjugation continues to attract considerable research efforts to develop new methodologies that match continuously increasing requirements of modern applications in terms of selectivity, stability, mildness, and preserving biomolecule integrity. For the purpose of this overview, the focus will remain on recent developments in bond-forming approaches in bioconjugation of native amino acid residues. Among about 20 different amino acids involved in protein composition, only a smaller number comprises appropriate targets for practical bioconjugation methods. In fact, only one-third of all amino acid residues represent chemical targets for the vast majority of bond-forming approaches.\n\nThe bioconjugation methodology of choice is selected according to the intrinsic reactivity of the targeted amino acid residue (acidity/basicity, electrophilicity/nucleophilicity, oxido-reductive characteristics) and its specific special environment (in-chain, N-terminal, C-terminal, location in a specific sequence, accessibility, etc.). In this review we will thus present the known bioconjugation strategies in regard to these parameters ranked in a descending order of frequency they are reported in literature.\n\n1. In-chain conjugation\n\n1.1 Lysine\n\nThe use of chemical groups that react with primary amines is one of the oldest and most versatile techniques for protein conjugation. Virtually all proteins contain primary amino groups in their structure. They can be divided into two groups: the α-amino group situated in the N-terminus of most polypeptide chains and ε-amino groups of lysine residue (Lys, K). Because these amino groups possess pKa values of about 8 and 10 (for α- and ε-amines respectively), in a vast majority of cases they are protonated at physiological pH and, therefore, occur predominantly on the solvent-exposed outside surfaces of protein tertiary structures. As a result, they become easily accessible to conjugation reagents introduced into the aqueous media.\n\nDeprotonated primary amines are the most nucleophilic among the available functional groups present in a typical protein. However, protonation drastically decreases their reactivity. As a consequence, despite the generally higher intrinsic nucleophilicity of Lys ε-amino groups, they require higher pH values to be uncovered by deprotonation, which allows distinguishing α- and ε-amino groups by adjusting the pH. That is to say, at the higher pH level, when both types of primary amines are deprotonated, Lys side chain amino groups are generally more reactive towards electrophiles, while at the lower pH it is the opposite because of their prior protonation (Fig. 1). At the acidic pH all amines are protonated and possess no significant nucleophilicity compared to other side chains present in proteins. In particular, free (non-disulfide-bonded) Cys residues are much stronger nucleophiles and, if accessible, will readily be modified by most amine-reactive reagents.\n\nIt is also to be mentioned that like any other parameters, nucleophilicity and basicity, as well as solvent exposure and accessibility of a particular amino group, are influenced by the microenvironment and can vary substantially, regarding the substrate. For instance, Westheimer and Schmidt have found the actual pKa of the amino group situated in the active site of acetoacetate decarboxylase to be 5.9, which is 4 pKa units less than that of an “ordinary” ε-amino group of lysine.29\n\nDepending on reaction conditions, selective modification of either N-termini (see Section 2) or Lys ε-amino groups can be achieved by using various chemical reagents. They generally belong to one of the following classes (in the order of relevancy): activated esters (fluorophenyl esters, NHS (N-hydroxysuccinimides),30 sulfo-NHS, acyl azides), isothiocyanates, isocyanates,31 aldehydes, anhydrides, sulfonyl chlorides, carbonates, fluorobenzenes, epoxides and imidoesters. Among this vast variety of reactive functions, NHS esters (and their more soluble sulfo-NHS analogues) and imidoesters represent the most popular amine-specific functional groups that are incorporated into commercially available reagents for protein conjugation and labelling.28\n\nDespite their name, amine-reactive reagents are not always entirely selective for amines. Firstly, as already mentioned before, they will react with any other stronger nucleophile, if the latter is present and accessible on a protein surface. Particularly, it concerns cysteine, tyrosine, serine and threonine side chains. Secondly, depletion of these highly activated reagents by hydrolysis is inevitable in aqueous solution. The rate of both side-reactions depends on the particular substrate, the conjugation partner, pH, temperature, and buffer composition. Evidently, buffers that contain free amines, such as TRIS (tris(hydroxymethyl)aminomethane), must be avoided when using any amine-reactive probes, since the rate of the reaction with buffer would greatly exceed that with protein amino groups.\n\n1.2 Serine and threonine\n\nWith pKa values > 13, the hydroxyl groups of serine (Ser, S) and threonine (Thr, T) are rather poor nucleophiles close to physiological pH. No examples of direct conjugation of in-chain serine and threonine have been therefore reported to date.\n\nHowever, highly amine selective N-hydroxysuccinimide (NHS) esters have been documented to give occasional side reactions with hydroxyl side chains.83,90,92,231 In a series of experiments, Miller et al. have demonstrated that the presence of histidine in sequences of the type His-AA-Ser/Thr or His-AA-AA′-Ser/Thr (where AA and AA′ stand for any amino acid) can significantly increase the reactivity of hydroxyl groups toward classical amine labelling agents (Fig. 18).85,86,88,232\n\nSimilarly, Mädler and Zenobi have reported that the guanidinium group of arginine can contribute to the reactivity of hydroxyl groups toward NHS esters and catalyse the nucleophilic substitution.233 In both cases, it is hypothesised that the imidazolyl and guanidine moieties of histidine and arginine, respectively, catalyse the reaction by stabilizing the transition state by means of hydrogen bonds and electrostatic interactions. This promoting effect is thought to be responsible for side reactions on several substrates while using cross-linking reagents.92,233\n\nDespite the fact that methodologies of selective in-chain serine and threonine labelling are rather scarce, these residues are of special interest for bioconjugation when located on the N-terminus (see Section 2.2).\n\n1.3 Cysteine\n\nCysteine (Cys, C) is perhaps the most convenient target for bioconjugation owing to the exceptionally high nucleophilicity of its sulfhydryl (–SH) side chain which, and particularly in its deprotonated thiolate form (–S−), largely exceeds the reactivity of any other nucleophilic function in proteins.234 Furthermore, its relative rarity in proteins present in living organisms (1–2%)235,236 and the ease of its introduction into a specific site by site-directed mutagenesis allows access to protein assemblies with a single cysteine at a predetermined position.237 Even in proteins with multiple cysteines, the multiplicity is usually much smaller compared to lysines, which makes thiol-reactive labelling the preferred approach over amine-reactive methodologies.\n\nIn proteins, thiols can also be generated by selectively reducing cystine disulfides with reagents such as dithiothreitol (DTT, D1532),238 2-mercaptoethanol (β-mercaptoethanol), or tris[2-carboxyethyl]phosphine (TCEP).239,240 Generally, all these reagents must be removed before conducting thiol-selective conjugation, as they will compete with target thiols in proteins otherwise.241 Unfortunately, removal of reducing agents is sometimes accompanied by air oxidation of thiols back to disulfides. Although, in contrast to the majority of thiol-reducing agents, TCEP does not contain the thiolate group, there have been several reports that it can react with α-halocarbonyls or maleimides and that labelling is inhibited when TCEP is present in the reaction medium.242,243\n\nDirect labelling of the thiolate group is usually achieved by either a nucleophilic addition or displacement reaction with the thiolate anion as the nucleophile. The substantially less dissociation energy of sulfhydryl groups compared to the corresponding alcohols provides much higher acidity of the former and, as a consequence, a wider availability of its slightly nucleophilic anionic form at physiological pH.\n\n1.4 Tryptophan\n\nTryptophan (Trp, W) is the second (after cysteine) low abundance amino acid with about 1% frequency (depending on the living organism),235 but approximately 90% of proteins contain at least one Trp residue in their sequence.439 The specific reactivity of tryptophan in proteins is one of the most challenging problems in bioconjugation. In spite of the variety of reagents introduced over the years for selective modification of tryptophan, only a few can be used for conjugation. For instance, such classically used species as Koshland's reagent (2-hydroxy-5-nitrobenzylbromide)440 or chlorosulfonium ions441 present a high degree of cross reactivity with nucleophilic side chains, nonetheless still being used in numerous studies. These are, for example, investigation of the role of tryptophan in active sites of enzymes,442 estimation of its content in proteins,443 or determination of the surface accessibility of Trp residues in proteins.444\n\n1.5 Histidine\n\nHistidine (His, H) is the only amino acid with a pKa in the physiological range, hence often found in active sites of many enzymes and is of crucial importance in mechanisms where abstraction or donation of a proton is needed. Because of its pKa value, both the acid and base forms are present at physiological pH (Fig. 47). Most of the studies on catalytic activity of enzymes and protein–protein interactions involving histidine-containing active centres were done by measuring the influence of site-specific modifications of His residues on the activity of the macromolecule. Main factors influencing histidine reactivity are (1) the pKa of the individual His residue, (2) solvent exposure of the residue, and (3) hydrogen bonding of the imidazolium ring. A vast number of studies have been conducted to date, nonetheless, exploiting a small number of chemical functions.\n\n1.5.4 Miscellaneous histidine-selective reagents. Some examples of the selective histidine tagging by reagents that, in general, react more avidly with other nucleophilic residues were reported to date. For instance, Pramanik and colleagues achieved dominant PEGylation rh-interferon-α2A on histidine at mildly acidic levels of pH with a classic amine PEGylation succinimidyl carbonyl precursor.473 Another group reported selective reaction of His residues of D-amino acid oxidase with dansyl chloride in 0.05 M phosphate buffer at pH 6.6.474 These reaction conditions resulted in virtually complete inactivation of the enzyme after the reaction and its complete reactivation after the reaction with 0.5 M hydroxylamine (NH2OH). Such reactivation excludes reaction of primary amino groups, and amino acid analysis suggested that the reaction had not occurred with an oxygen nucleophile such as serine or tyrosine. Even α-halo carbonyl compounds – phenacyl bromides, α-halo carboxylic acids and amides – classically known for their selectivity towards thiols electrophiles as were found to be histidine selective on several substrates and in carefully tuned conditions.475–479\n\nDescribed by Pauly in the beginning of the 20th century,480,481 the reaction with diazonium salts has been only used for colorimetric determining of His residues482 and was not further elaborated for bioconjugation. Other classical examples of chemical modification of histidine are mainly reactions with pyrocarbonate, sulfonyl chlorides, sulfonic esters, phenacyl- and acylbromides and activated esters.229 These electrophiles react readily with other nucleophilic groups presented in proteins (thiols, amines, alcohols, or guanidino groups) and require a careful tuning of the reaction conditions to achieve sufficient selectivity. For instance, at low pH (generally < 6.0) these reactions are quite selective for histidine, as the main side reaction with the ε-amino group of lysine proceeds very slowly.483\n\nReader should, nonetheless, be aware, that these examples do not represent a general rule, but an exception from it. To avoid the reactions of more nucleophilic functions, the His residue must have been located in a unique microenvironment476,477 or have an enhanced nucleophilic character,478 but even in this case, prior modifications of highly reactive Cys residues are often inevitable.479\n\n1.6 Tyrosine\n\nTyrosine (Tyr, Y) is one of the important amino acid residues which is known to be the active centre in many enzymes (notably tyrosine-specific protein kinases) and is used in signal transduction and cell signalling.484,485 Occurring with intermediate to low frequency in native proteins, tyrosine is often considered as an attractive target in bioconjugation, despite being often partially or completely buried due to the amphiphilic nature of the phenolic group.\n\nThe reactivity of tyrosyl moiety is easily influenced by its deprotonation, which is a function of the microenvironment inside the protein. All described methodologies take advantage of either the peculiar chemical properties of the electron-rich aromatic ring, or the easiness of the tyrosine hydroxyl group to be transformed into highly reactive phenolate.\n\n1.7 Arginine\n\nWith a pKa value above 12, arginine (Arg, R) is mainly presented in its protonated form in acidic, neutral, and even most basic environments. Effective delocalisation of a positive charge between nitrogen lone pairs and the double bond favours the formation of hydrogen bonds539,540 and makes the guanidinium side chain of arginine the least acidic cationic group among all 20 natural amino acids (Fig. 60).541\n\nHowever, the pKa value of arginine was found to vary significantly in the microenvironments within certain proteins,542,543 allowing, in terms of Leitner and Lindner,544 the grouping of arginines in “exposed” or “partially buried” residues, basing on the difference of their reactivities.\n\nMost of the described approaches for arginine labelling and modification exploit the chemistry of α-dicarbonyl compounds. For instance, introduced by Takahashi545 as an arginyl reagent, phenylglyoxal has since been applied for the study of complex systems in the past decade.546–550 The reaction occurs under mild conditions and consists of two steps: first addition of phenylglyoxal resulting in the formation of hydrolytically instable imidazolidine diol, and the second step results in a relatively stable addition product (Fig. 61).\n\nSubstituted phenylglioxal analogs, such as p-hydroxyphenylglyoxal, p-nitrophenylglyoxal and 4-hydroxy-3-nitrophenylglyoxal, p-azidophenylglyoxal (APG) were reported for spectrophotometric and cross-linking study of the modification of arginine in proteins.551–555 None of these linkers have however been used in bond-forming conjugation. Because phenylglyoxal, like glyoxal, reacts with ε-amino groups at a significant rate,545 many efforts were made to increase its selectivity towards guanidinium residue. Cheung and Fonda have studied the effect of buffers and pH on the reaction rate556 and found that the reaction of arginine is greatly accelerated in bicarbonate–carbonate buffer systems, possibly due to the stabilisation of the obtained diol.\n\nGeminal diones – namely 2,3-butanedione (introduced by Yankeelov)557,558 and 1,2-cyclohexanedione (introduced by Itano)559 – are another well-characterised reagents for the modification of Arg residues. The reaction progresses through the pathway that is similar to the phenylglyoxal addition. However, it was not until the observation that borate had a significant effect on the selectivity of the reaction that the use of this reagents became practical.560,561 The presence of borate in the solution allows shifting of the equilibrium during the addition to a guanidine moiety through the stabilisation of reversibly obtained diol (Fig. 62).\n\nIn 2005, using this approach, Lindner and colleagues have described a method for the selection of arginine-containing peptides from a tryptic digest of the model proteins (BSA, lysozyme, ovalbumin) by a solid phase capture and release.562 First, arginine containing peptides presented in the digest were covalently modified on the guanidine moiety with 2,3-butanedione and phenylboronic acid under alkaline conditions. Polymeric materials allowing the immobilisation of phenylboronic acid were then used to capture the arginine-peptides on a solid support while washing away all not covalently bonded arginine-free peptides. Finally, the arginine-peptides were cleaved again from the boronic acid beads due to the reversibility of the reaction. Photoactivable bifunctional reagents for cross-linking of arginine moieties have been elaborated by Ngo et al. and Politz et al. to study enzymes with an arginine at their active sites.555,563\n\nArginine-specific PEGylation of lysozyme using polyethylene glycols containing an α-oxo-aldehyde motif in borate buffer was recently reported by Gauthier and Klok564 and represents mild and selective method for protein modification (Fig. 63). Other methods described to date565,566 possess selectivities, which are not sufficient (especially in the presence of Lys moieties) to consider them as suitable for bioconjugation.\n\n1.8 Aspartic and glutamic acids\n\nCarboxylic acid groups can be found in protein structure either on its C-terminus, or as side chains of Asp and Glu. Due to the low reactivity of carboxylate in water, it is usually difficult to selectively conjugate proteins at these moieties. Carboxylic acid should thus generally be converted to a more reactive ester by means of so called activating reagents.\n\nFor more than a half century, carbodiimide-mediated activation is the most extensively used methodology for the modification of free-acids in protein.567,568 The reaction of carbodiimides with protonated carboxyl groups yields activated acylisoureas, which then react smoothly with a variety of nucleophiles, namely amines (Fig. 64).569 It is important to utilise weakly basic amines, that remain deprotonated and thus reactive at pH below 8.0, to avoid protein cross-linking occurring at higher pH values. For this reason, weakly basic hydrazides are often reagents of choice in coupling reactions with activated carboxylic acids.570 Although water-insoluble carbodiimides (DCC, DIC) still continue to be useful for acid-selective protein conjugation,571,572 most current reports exploit water-soluble carbodiimides such as 1-ethyl-3-(3-dimethyl-aminopropyl)carbodiimide (EDC). Developed by Sheehan and Hlavka573,574 these carbodiimides first proved their especial usefulness as zero-length cross-linking reagents to study proteins.574 Subsequent studies were devoted for the application of carbodiimides for quantitation of accessible carboxyl groups in proteins,567,568,575 preparation of antigenic conjugates,576 and protein immobilisation.577\n\nAs mentioned previously, the upper limit for the optimal pH of carboxylate conjugation is defined by the reactivity of free amino groups present in protein. The lower limit is mainly determined by aqueous stability of the activating reagent. Borders and co-workers578 studied the stability of EDC in aqueous solution. It was found that EDC has a T12 of 37 hours (pH 7.0), 20 hours (pH 6.0), and 3.9 hours (pH 5.0) in 50 mM MES buffer at 25 °C; in the presence of 100 mM glycine, the T12 values were 15.8 hours, 6.7 hours, and 0.73 hours respectively. This supports the optimal pH for acid-selective conjugation to be in a range from 6.0 to 7.0. NHS (or its water-soluble analogue sulfo-NHS) is often included in coupling protocols to improve efficiency or to create a more stable intermediate. Possible side-reactions involving activating reagents were recently reviewed by Valeur and Bradley.579\n\nWoodward's reagent K (N-ethyl-5-phenylisoxazolium-3′-sulfonate)580 and analogous substrates were used as activating reagents of carboxyl groups for synthetic purposes. Bodlaender et al.581 used N-ethyl-5-phenylisoxazolium-3-sulfonate, the N-alkyl derivatives of 5-phenylisoxazolium fluoroborate, to activate carboxyl groups on trypsin for subsequent modification with methylamine or ethylamine.\n\nLastly, several studies revealed unexpected examples of carboxyl group modification with reagents usually reacting far more effectively with other nucleophiles. For instance, p-bromophenacyls and iodoacetamides have been found to selectively alkylate carboxylic acid moieties of pepsin and ribonuclease T1 respectively.582–584 However, the applicability of these reagents is not general and is appropriate on specific substrates only.\n\n1.9 Methionine\n\nIn spite being often considered a rather simple target for chemical modification (mainly through the oxidation and the reaction with α-halo acetic acids and their derivatives),585,586 only a handful of conjugation methodologies involving methionine (Met, M) were described up to the present.\n\nAll approaches described in literature exploit alkylation of Met residues in acidic media. Although many nucleophilic functional groups present in proteins can react with alkylating reagents, at low pH all of them except methionine exist in protonated forms, which greatly decreases their reactivity.587 Consequently, alkylations of other nucleophilic functional groups, such as thiols, are commonly conducted at high pH,400 while methionine is the only functional group in proteins able to react with alkylating reagents at low pH.\n\nBasing their research on pioneering studies being done by Toennies in the 1940s,589,590 Kramer and Deming have recently reported a reversible chemoselective labelling of methionine in peptides and polypeptides.588 Treatment of the model peptide (PHCRKM) with alkylating reagents of different structures in 0.2 M aqueous formic acid (pH 2.4) gave a single product, where only the Met residue was alkylated. This resulting sulfonium salts can readily be dealkylated by addition of pyridine-2(1H)-thione (PyS) to give the starting peptide as the sole product along with the alkylated PyS byproduct. The removal reaction was found to be selective and allows selective dealkylating using concentrations of PyS that do not react with the disulfide bond in cystine under identical conditions (Fig. 65).\n\n2. N-terminal conjugation\n\n2.1 α-Amino groups\n\nThe most important thing to note about N-terminal amino groups is that these are the only primary amines present in the protein structure that possess an adjacent amide bond in α-position, which slightly influences their reactivity. Consequently, the majority of classical methodologies exploit this peculiarity of the N-terminus.\n\n2.1.1 Classical approaches. As rather unpolarizable nucleophiles, amines react preferentially with hard electrophiles like acid anhydrides and acyl halogenides.591 The anchimeric influence of the adjacent amide bond consists in the lowering the pK value of the amine by electron withdrawal. Consequently, this makes the discerning of N-terminal amino groups from the ε-amino groups of Lys residues achievable by working at a pH close to their pK values, i.e. under slightly acidic conditions. That is, virtually all methodologies described in the Section 1.1 of this review are, to some extent, applicable for selective labelling of N-terminal amino groups of the proteins.\n\nIn the classical work on acetylation of the growth hormone, Reid592 has for the first time demonstrated the possibility of selective modification of N-termini, if acetylation is performed with a relatively small amount of acetic anhydride. Further development of this approach has in several protocols for selective labelling of α-amino groups of proteins,3,593 peptides,594,595 and proteomes.596–598 Under optimal reaction conditions, the use of a 5-fold excess of amine-reactive reagent in PBS (pH 6.5) at 4 °C, high levels of selectivity can be achieve after 2–24 hours of reaction. However, the preference for terminal amino groups achieved by control of pH is rather limited, mainly owing to the fickleness of the pKa of the amino group depending on the microenvironment and reaction conditions. Consequently, more proficient methods that rely upon increased chelating ability of N-termini,599 direct participation of the adjacent side chains or peptide bond,600,601 were developed and represent to date preferential approaches for bioconjugation.\n\n2.2 Serine and threonine\n\nIn 1960 Waller and Dixon have described the first procedure for selective N-terminal modification of peptides. It consisted of preparation of corticotrophin selectively acetylated on its terminal serine.633 Although being possible only under highly denaturing conditions of alkali exposure, the approach allowed for a spontaneous intramolecular O → N acyl transfer634 on the N-terminal Ser residues, while O-acetyl groups of in-chain Ser, Thr and Tyr residues were hydrolysed. The general idea of overcoming the entropy barrier of an otherwise slow intermolecular process by bringing two reacting partners together through a covalent linkage to initialize an intramolecular reaction has been later transformed into a large variety of selective modification reactions.\n\n2.3 Cysteine\n\nGeneration of N-terminal Cys residue for native chemical ligation can be accomplished using solid-phase peptide synthesis,659 proteolytic processing,660 or by the spontaneous hydrolysis of intein fusion protein.661 Moreover, genetically directed, site-specific incorporation of 1,2-aminothiols handle into proteins has been recently reported by Chin and associates.662\n\n2.4 Tryptophan\n\n2.4.2 Pictet–Spengler reaction. Another approach for the ligation of unprotected peptides was proposed by Li et al.788 and exploited the Pictet–Spengler reaction: an acid-catalysed intramolecular condensation between an iminium ion and an aromatic C-nucleophile described in 1911.789 This non-natural ligation (peptides are linked by non-natural bonds) involves reaction of two peptide partners in acetic acid: one containing a Trp residue at its N-term and another with a C-terminal aldehyde function. The latter should generally be introduced by means of solid-phase peptide synthesis on acetal resin (described by the same authors).\n\n2.4.3 N-Acyl tryptophan isopeptides. Lastly, an interesting example of native N-terminal Trp ligation, mechanistically very similar to NCL (see Section 2.3.1), was recently reported by Popov et al.790 The key intermediates of this methodology – N-acyl tryptophan isopeptides – undergo selective acyl transfer to yield natural peptides. These are, however, not accessible directly by methods reported so far, which substantially restricts the applicability of the methodology.\n\n2.5 Histidine\n\nDespite being known for its particular importance for the acyl transfer in many enzymatic processes,665 histidine has been rarely used for bioconjugation. The only study describing the ligation of N-terminal His peptides with activated thioester was reported by Zhang and Tam.791\n\nEllman's regent348 was used to activate the C-terminal peptide thiocarboxylic acid by forming acyldisulfide derivative, which is then nucleophilically attacked by N-terminal histidine. Captured by the imidazole of the N-terminal histidine, the obtained Nim-acyl intermediate is hypothesised to undergo Nim → Nα shift to form histidine at the ligation site (Fig. 90). However, the Nim-acyl intermediate has not been isolated and it is quite possible that regioselectivity is obtained simply because of anchimeric assistance of the proximal imidazole moiety at the ligation site.\n\nInterestingly, no sign of coupling reaction has occurred when a corresponding non-activated C-terminal thiocarboxylic acid is participating in the reaction instead of the acyldisulfide. The reaction pH plays an important role on the effectiveness of the reaction. Only when maintained at slightly acidic values (pH 5–6) and in the absence of the thiol nucleophiles, would the imidazolyl moiety of histidine be the sole nucleophile present in the polypeptide. This methodology has been applied to generate histidine-containing peptides with yields up to 75%.\n\n2.6 Selenocysteine\n\nSelenium and sulphur belong to the same main group of elements; therefore, 21st proteinogenic amino selenocysteine and Cys residue exhibit rather similar properties in terms of reactivity for bioconjugation.792–794 For instance, both Hilvert's738 and Raines's group736 demonstrated that C-terminal peptide thioesters react smoothly with peptide fragments containing a N-terminal selenocysteine in exactly the same manner as with corresponding cysteine analogues. Presumably proceeding through the same mechanism as NCL (Section 2.3.1), the first step of the ligation process consists in the nucleophilic attack on the thioester by selenolate to give a selenoester intermediate that subsequently rearranges to give a native chemical bond.\n\nSec ligation can be chemoselective when conducted at slightly acidic pH. Low intrinsic pKa values of selenocysteine (5.2)795 and consequently its higher dissociation level at low pH, endows this amino acid with unique biochemical properties, allowing regiospecific covalent conjugation with electrophilic compounds in the presence of the side chains of all other natural amino acids including the thiol group of Cys (pKa 8.3). For instance, the reaction rate with selenocysteine was found to be 1000 fold faster than with cysteine at pH 5.0.736 Moreover, the lower pH generally suppresses β-elimination of the selenol group from selenocysteine resulting in the obtaining of unreactive dehydroalanine.392\n\nInitially, considerable efforts were made to show the applicability of selenocysteine NCL for the preparation of selenium-containing derivatives of enzymes and benchmarking activities thereof. Hilvert and associates synthesised a C38U analogue of bovine pancreatic trypsin inhibitor (BPTI). Amusingly, the wild-type BPTI and its artificial analogue folded into alike conformations and demonstrated similar inhibiting affinity of trypsin and chymotrypsin.738 Raines et al. selected 124-residue ribonuclease A (RNase A) as a model protein for the investigations.736 DNA recombinant technology was utilised to prepare a C-terminal thioester fragment corresponding to residues 1–109, while standard solid phase peptide synthesis methodology was used to obtain a N-terminal Cys and Sec peptides corresponding to residues 110–124 (Fig. 91). Just as in the case of BPTI, the semisynthetic wild-type RNase A and C110U RNase A presented equivalent ribonucleolytic activities. Further advances in the field of Sec-NCL have resulted in synthesis and investigations of other different proteins such as seleno-glutaredoxin,796 azurin,797,798 and thioredoxine reductase.\n\nEase of the post-ligation transformation of selenocysteine to alanine (by deselenisation), dehydroalanine (by β-elimination) or non-natural amino acids (by addition reaction to dehydroalanine, see Section 1.3.8) became a spur to a further propagation of Sec-mediated methodologies as very effective tools in rational design of peptides and proteins. Quaderer and Hilvert799 exploited such transmutations of selenocysteine to access a series 16-residue cyclic peptides (Fig. 92).\n\nIn this initial report, the deselenisation step was conducted rather harshly (RANEY® Ni, H2), implying that all Cys residues (if there were any) would have been reduced as well. Recently, however, Dawson and collaborators735 have demonstrated that selenocysteine can be chemoselectively deselenated with TCEP in the presence of cysteines. This allowed overpassing the main limitation of the NCL-desulfurisation strategy (see Section 2.3.1.4), namely the inability to control regioselectivity of desulfurisations if several cysteines are present in the peptide or protein, and yielded in a pool of NCL-deselenisation strategies for mild incorporation of alanine, phenylalanine and proline into the ligation site by classic NCL approaches (see Table 2). Finally, selenocysteine peptides were found to efficiently undergo reverse NCL at acidic pH and thus to be of particular interest for the generation of thioesters by sequential N → Se acyl-transfer and substitution of the obtained selenoester by exogenous thiol (see Section 2.3.1.3).745\n\nBecause the incorporations of selenocysteine by the cell translational machinery are generally very laborious,800,801 selenopeptides are mainly obtained by SPPS.736,737,794\n\n2.7 Proline\n\nThe oxidative coupling of o-aminophenols and o-catechols recently reported by Francis and collaborators802 represents an interesting approach for selective N-terminal conjugation on proteins. The strategy consists in prior in situ oxidation of o-aminophenols and o-catechols to active coupling species using potassium ferricyanide (Fig. 93a) followed by their reaction with a protein (Fig. 93a). This approach was shown to work particularly well with proline (due to increased nucleophilicity thereof) and can therefore be considered as N-terminal Pro selective methodology.802 The key advantage of the approach compared to the majority of N-terminal selective methodologies is its fast second-order kinetics in a single step transformation, which does not require prior oxidation of the N-terminus. Free cysteine residues, however, are also reactive during the oxidative coupling and must thus be protected, which represents the main drawback of the approach.\n\n3. C-terminal conjugation\n\nChemical methods for C-termini conjugation are rather scarce. Definitely, previously mentioned approaches for the conjugation of side-chain carboxylates (see Section 1.5) can also be applied effectively to modify the terminal carboxylates. The selectivity, however, would be the main issue, for up to date there is no described method for somewhat selective activation of N-terminal carboxylates by any activating reagent.\n\nBecause of the impetuous development of NCL (see Section 2.3.1), requiring C-terminal thiolates as reacting partners for N-terminal Cys proteins, those became widely accessible, namely by means of SPPS. A perspective approach, exploiting these advances was proposed by Goody803 and collaborators, who developed a protocol for selective transformation of C-terminal thioesters to corresponding hydroxylamines, enabling thus the application of aldehyde- and ketone-selective methodologies on the C-terminus.\n\nOn the other hand, the unique position of protein C-termini has stimulated numerous efforts to target this location, which resulted in numerous enzymatic and intein-based approaches for C-terminal-selective protein modification.804–809 These methodologies are, however, not covered by this review devoted to chemical methods of bioconjugation.\n\n4. Sequence-selective approaches\n\nSeveral especially useful methodologies in bioconjugation exploit not a specific property of the residue, or its peculiar position in protein, but rather the synergetic effect of a batch of neighbouring amino acid residues. For instance, an example of such selectivity is the aforementioned selective modification of His-AA-Ser and His-AA-Thr peptide motifs (see Section 1.2) by usually promiscuous activated esters. In this case, the His imidazolyl side chain located in close proximity to Ser/Thr side chains increased the reactivity thereof towards electrophiles.\n\nMetal-chelation methodologies are perhaps the most elaborated among sequence-selective approaches (Fig. 94).810 The oligo-histidine sequence (usually H6), called His-tag, is known to interact robustly with transition-metal complexes, including a nitrilotriacetic acid (NTA) complex of Ni2+, therefore the sequence is widely used for protein purification by affinity chromatography. Similarly, oligo-aspartates (most often (D4)n, n = 1–3) were developed for selective labelling with multinuclear Zn2+ complexes.811,812 The tetracysteine motif (CCPGCC) was reported to especially effectively chelate biarsenical dyes such as 4′,5′-bis(1,3,2-dithioarsolan-2-yl)fluorescein (FlAsH),5,813 while a similar structural tetraserine sequence (SSPGSS) was found to be selective for diborate-scaffolds.\n\n5. Proximity-driven modifications\n\nAll the above-mentioned methodologies are mainly residue-specific. That is to say, they exploit specific reactivity of the functional group of interest or of an assembly of residues. As a result, bioconjugations of highly nucleophilic Cys, Lys, and Tyr residues with electrophilic reagents are definitely prevalent among described methodologies.\n\nThe inherent reactivity is rare to be overcome, which largely limits of the scope of known methods for bioconjugation of the amino acids possessing low nucleophilicity. However, bringing the reaction partners into close proximity can accelerate a reaction thereof, which would not otherwise be possible because of the presence of other more reactive species. Routinely exploited by enzymes, this approach enables selectivity on the basis of the molecular shape rather than reactivity or the local environment (Fig. 95).\n\nDeveloped by Hamachi and collaborators in 2006,462 the post-affinity-labelling approach can be used for the selective tethering a functional molecule at the proximity of the active site of enzymes. This method was then used on numerous substrates and enlarged the scope of selective conjugation especially on histidine and tyrosine (see Section 1.5.1).462,463,486,814 Despite these successes, a prevalent limitation of the applicability of the method due to the possible modification of the residues situated only in the vicinity of ligand-binding pocket of the target protein prevents this methodology from becoming a general approach for protein labelling.\n\nIn 2010, exploiting similar idea, Popp and Ball454 envisioned the combination of two previously described techniques: the coiled-coil based molecular recognition of complementary peptides455,815–817 and high catalytic activity of dirhodium complexes on carbene C–H insertion, previously reported by Francis and collaborators452 for the selective modification of tryptophan (see Section 1.4.2). Two complementary peptides: one, containing a dirhodium catalytic centre (precomplexated through two glutamate side chains), and another, containing a side chain to be modified are thus involved in this methodology (Fig. 96a). Because of the compelled proximity of the side chain of interest and the active catalytic centre in the obtained supramolecular assembly, the reaction of rhodium-catalysed C–H insertion is largely accelerated (more than 103 times).818\n\nAs a result, the conjugation of amino acid residues with lower reactivities becomes possible. This allowed to expand the scope of originally tryptophan-selective dirhodium carbene methodology first to the other aromatic residues, phenylalanine and tyrosine,454 and then to over half of the naturally occurring amino acid residues (Fig. 96b).818 To date, dirhodium metallopeptide represent the only reported method for selective modification of Gln, Asn, and Phe side chains. The authors have also demonstrated the possibility to apply their methodology on chimeric proteins, containing fused coils,456 as well as on full-sised natural proteins possessing coiled-coils in their structures.818\n\nDespite its important potential, the metallopeptides methodology is however not devoid of drawbacks. Because binding to dirhodium is nonselective and thus cannot be performed in the presence of other carboxylate-containing peptides, rhodium-peptide complexes must be synthesised beforehand, which is often challenging mainly due to their poor solubility.819 Moreover, the method is restricted to proteins containing coiled coil fragments in their structures, which in case of the vast majority of targets would mean the need for resource- and time-consuming expression of fused proteins.\n\nAnother approach, developed by Silverman and colleagues, exploits self-assembling of complementary DNA to bring into proximity two reacting fragments and allowed, although only on simple substrates, selective phosphorylation of tyrosine and serine, otherwise not feasible.538\n\nBeyond coiled coils and DNA-based preorganisation, the principles of proximity-driven selectivity should be extended to other helix-binding protein domains and to biological molecular recognition generally. A significant broadening of the applicability of this elegant approach for protein modification, biochemistry and biomaterials engineering is anticipated in the nearest future.\n\nConclusions\n\nThe field of bioconjugation has expanded in the last 100 years and passed from a blind-eye modification of proteins one could found in nature to a well-established independent domain full of approaches allowing precise and reliable introduction of various tags into proteins' structure.\n\nMany, if not most of these methods, however, often possess drawbacks limiting their general applicability. This fact has become of special consideration with a rise of novel exigent applications for bioconjugation, namely the preparation of new therapeutic conjugates, vaccines, and biomaterials. Also tremendous progress in the sensitivity of analytical methodologies as well as the need to work with smaller and smaller amounts of sample, often-unstandardized patient samples, highlighted the need for more efficient, selective and reliable bioconjugation methods.\n\nMoreover, some parameters of the mode of conjugation, previously completely neglected, were recently revealed to be of paramount importance. For instance, the stability of the generated linkage and the distribution of products generated upon conjugation can be determining for the overall efficiency of the conjugate.\n\nOverall, we believe that intensive ongoing research in the field of bioconjugation will result in more efficient and selective methodologies allowing specific conjugation of native proteins in complex biological media, and ultimately in living organisms.\n\nAcknowledgements\n\nWe thank Dr S. Kolodych (Syndivia SAS), Dr J.-Y. Bonnefoy (Syndivia SAS), Dr A. Osypenko (UDS), and Dr M. Recher (UDS) for fruitful discussions that led to the redaction of this manuscript. We also acknowledge the financial support from SATT Conectus “BioReLiable” project, CNRS, University of Strasbourg, and International Center for Frontier Research in Chemistry (icFRC).\n\nReferences\n\nS. Zalipsky, Bioconjugate Chem., 1995, 6, 150–165 CrossRef CAS.\n\nJ. M. Harris and R. B. Chess, Nat. Rev. Drug Discovery, 2003, 2, 214–221 CrossRef CAS PubMed.\n\nD. P. Baker, E. Y. Lin, K. Lin, M. Pellegrini, R. C. Petter, L. L. Chen, R. M. Arduini, M. Brickelmaier, D. Wen, D. M. Hess, L. Chen, D. Grant, A. Whitty, A. Gill, D. J. Lindner and R. B. Pepinsky, Bioconjugate Chem., 2006, 17, 179–188 CrossRef CAS PubMed.\n\nS. J. Bell, C. M. Fam, E. A. Chlipala, S. J. Carlson, J. I. Lee, M. S. Rosendahl, D. H. Doherty and G. N. Cox, Bioconjugate Chem., 2008, 19, 299–305 CrossRef CAS PubMed.\n\nB. A. Griffin, Science, 1998, 281, 269–272 CrossRef CAS.\n\nH. M. O'Hare and K. Johnsson, Curr. Opin. Struct. Biol., 2007, 17, 488–494 CrossRef PubMed.\n\nX. Michalet, S. Weiss and M. Jäger, Macromolecules, 2006, 106, 1785–1813 CAS.\n\nC. A. Royer, Chem. Rev., 2006, 106, 1769–1784 CrossRef CAS PubMed.\n\nC. R. Bagshaw and D. Cherny, Biochem. Soc. Trans., 2006, 34, 979–982 CrossRef CAS PubMed.\n\nB. F. Cravatt, A. T. Wright and J. W. Kozarich, Annu. Rev. Biochem., 2008, 77, 383–414 CrossRef CAS PubMed.\n\nM. Fernández-Suárez and A. Y. Ting, Nat. Rev. Mol. Cell Biol., 2008, 9, 929–943 CrossRef PubMed.\n\nQ. Wang, T. Lin, L. Tang, J. E. Johnson and M. G. Finn, Angew. Chem., Int. Ed., 2002, 41, 459–462 CrossRef CAS.\n\nJ. C. Smith, K.-B. Lee, Q. Wang, M. G. Finn, J. E. Johnson, M. Mrksich and C. A. Mirkin, Nano Lett., 2003, 3, 883–886 CrossRef CAS.\n\nD. W. P. M. Löwik, I. O. Shklyarevskiy, L. Ruizendaal, P. C. M. Christianen, J. C. Maan and J. C. M. van Hest, Adv. Mater., 2007, 19, 1191–1195 CrossRef PubMed.\n\nK. L. Christman, R. M. Broyer, Z. P. Tolstyka and H. D. Maynard, J. Mater. Chem., 2007, 17, 2021 RSC.\n\nM. J. Abedin, L. Liepold, P. Suci, M. Young and T. Douglas, J. Am. Chem. Soc., 2009, 131, 4346–4354 CrossRef CAS PubMed.\n\nL. S. Witus and M. B. Francis, Acc. Chem. Res., 2011, 44, 774–783 CrossRef CAS PubMed.\n\nM.-L. Chen, A. K. Adak, N.-C. Yeh, W.-B. Yang, Y.-J. Chuang, C.-H. Wong, K.-C. Hwang, J.-R. R. Hwu, S.-L. Hsieh and C.-C. Lin, Angew. Chem., Int. Ed., 2008, 47, 8627–8630 CrossRef CAS PubMed.\n\nA. Hucknall, D. H. Kim, S. Rangarajan, R. T. Hill, W. M. Reichert and A. Chilkoti, Adv. Mater., 2009, 21, 1968–1971 CrossRef CAS PubMed.\n\nY.-L. Huang and C.-Y. Wu, Expert Rev. Vaccines, 2010, 9, 1257–1274 CrossRef CAS PubMed.\n\nS. Aggarwal, Nat. Biotechnol., 2010, 28, 1165–1171 CrossRef CAS PubMed.\n\nA. Mullard, Nat. Rev. Drug Discovery, 2013, 12, 329–332 CrossRef CAS PubMed.\n\nY.-L. Huang, J.-T. Hung, S. K. C. Cheung, H.-Y. Lee, K.-C. Chu, S.-T. Li, Y.-C. Lin, C.-T. Ren, T.-J. R. Cheng, T.-L. Hsu, A. L. Yu, C.-Y. Wu and C.-H. Wong, Proc. Natl. Acad. Sci. U. S. A., 2013, 110, 2517–2522 CrossRef CAS PubMed.\n\nR. Adamo, A. Nilo, B. Castagner, O. Boutureira, F. Berti and G. J. L. Bernardes, Chem. Sci., 2013, 4, 2995–3008 RSC.\n\nC. Gruttner, K. Muller and J. Teller, IEEE Trans. Magn., 2013, 49, 172–176 CrossRef.\n\nA. Sinz, J. Mass Spectrom., 2003, 38, 1225–1237 CrossRef CAS PubMed.\n\nM. J. Hinner and K. Johnsson, Curr. Opin. Chem. Biol., 2010, 21, 766–776 CrossRef CAS PubMed.\n\nG. T. Hermanson, Bioconjugate Techniques, Academic Press, 2008 Search PubMed.\n\nF. H. Westheimer and D. E. Schmidt, Biochemistry, 1971, 10, 1249–1253 CrossRef CAS.\n\nG. W. Anderson, J. E. Zimmerman and F. M. Callahan, J. Am. Chem. Soc., 1964, 86, 1839–1842 CrossRef CAS.\n\nA. Lowe, Proc. R. Soc. Med., 1970, 63, 367–368 CAS.\n\nA. H. Coons, H. J. Creech, R. N. Jones and E. Berliner, J. Immunol., 1942, 45, 159–170 CAS.\n\nM. E. Annunziato, U. S. Patel, M. Ranade and P. S. Palumbo, Bioconjugate Chem., 1993, 4, 212–218 CrossRef CAS.\n\nH. J. Creech and R. N. Jones, J. Am. Chem. Soc., 1941, 63, 1670–1673 CrossRef CAS.\n\nL. Goodfriend and A. H. Sehon, Can. J. Biochem., 1958, 36, 1177–1184 CrossRef CAS.\n\nA. Rifai and S. S. Wong, J. Immunol. Methods, 1986, 94, 25–30 CrossRef CAS.\n\nA. Todrick and E. Walker, Biochem. J., 1937, 31, 297–298 CAS.\n\nP. Edman, Acta Chem. Scand., 1950, 4, 283–293 CrossRef CAS PubMed.\n\nD. Podhradský, Ĺ. Drobnica and P. Kristian, Experientia, 1979, 35, 154–155 CrossRef.\n\nR. J. Seiwald, J. L. Riggs, J. H. Burckhalter, C. M. Downs and T. G. Metcalf, Am. J. Pathol., 1958, 34, 1081–1097 Search PubMed.\n\nR. P. Haugland, Molecular probes, in Handbook of fluorescent probes and research chemicals, 1996 Search PubMed.\n\nJ. Tuls, L. Geren and F. Millett, J. Biol. Chem., 1989, 264, 16421–16425 CAS.\n\nL. D. Burtnick, Biochim. Biophys. Acta, 1984, 791, 57–62 CrossRef CAS.\n\nM. Miki, Eur. J. Biochem., 1987, 164, 229–235 CrossRef CAS PubMed.\n\nM. Miki, J. Biochem., 1989, 106, 651–655 CAS.\n\nA. Bellelli, R. Ippoliti, M. Brunori, Z. Kam, M. Benveniste, F. Emmanuel, E. Turpin, A. Alfsen and J. P. Frénoy, Biochem. Biophys. Res. Commun., 1990, 169, 602–609 CrossRef CAS.\n\nR. E. Dedmon, A. W. Holmes and F. Deinhardt, J. Bacteriol., 1965, 89, 734–739 CAS.\n\nL. Amante, A. Ancona and L. Forni, J. Immunol. Methods, 1972, 1, 289–301 CrossRef CAS.\n\nA. F. Barbet and T. C. McGuire, Proc. Natl. Acad. Sci. U. S. A., 1978, 75, 1989–1993 CrossRef CAS.\n\nM. Schultzberg, J. M. Lundberg, T. Ho kfelt, L. Terenius, J. Brandt, R. P. Elde and M. Goldstein, Neuroscience, 1978, 3, 1169–1186 CrossRef CAS.\n\nW. P. Carney, R. H. Rubin, R. A. Hoffman, W. P. Hansen, K. Healey and M. S. Hirsch, J. Immunol., 1981, 126, 2114–2116 CAS.\n\nA. Varadarajan, R. M. Sharkey, D. M. Goldenberg and M. F. Hawthorne, Bioconjugate Chem., 1991, 2, 102–110 CrossRef CAS.\n\nR. Pei, M. Arjomand-Shamsai, C. T. Deng, A. Cesbron, J. D. Bignon and J. H. Lee, Tissue Antigens, 1993, 41, 200–203 CrossRef CAS PubMed.\n\nM. Edidin, Y. Zagyansky and T. Lardner, Science, 2003, 191, 466–468 Search PubMed.\n\nK. K. Huang and C. R. C. Cantor, J. Mol. Biol., 1972, 67, 265–275 CrossRef CAS.\n\nS. H. Blose, J. Cell Biol., 1980, 86, 608–615 CrossRef.\n\nS. Ohkuma, Y. Moriyama and T. Takano, Proc. Natl. Acad. Sci. U. S. A., 1982, 79, 2758–2762 CrossRef CAS.\n\nS. J. Morrison, H. D. Hemmati, A. M. Wandycz and I. L. Weissman, Proc. Natl. Acad. Sci. U. S. A., 1995, 92, 10302–10306 CrossRef CAS.\n\nC. A. Gabel, E. M. Eddy and B. M. Shapiro, J. Cell Biol., 1979, 82, 742–754 CrossRef CAS.\n\nP. Rosa-Neto, B. Wängler, L. Iovkova, G. Boening, A. Reader, K. Jurkschat and E. Schirrmacher, ChemBioChem, 2009, 10, 1321–1324 CrossRef CAS PubMed.\n\nK. E. Linder, M. D. Wen, D. P. Nowotnik, M. F. Malley, J. Z. Gougoutas, A. D. Nunn and W. C. Eckelman, Bioconjugate Chem., 1991, 2, 160–170 CrossRef CAS.\n\nC. F. Meares, M. J. McCall, D. T. Reardan, D. A. Goodwin, C. I. Diamanti and M. McTigue, Anal. Biochem., 1984, 142, 68–78 CrossRef CAS.\n\nS. S. Mirzadeh, M. W. M. Brechbiel, R. W. R. Atcher and O. A. O. Gansow, Bioconjugate Chem., 1989, 1, 59–65 CrossRef.\n\nD. S. Wilbur, M.-K. Chyan, D. K. Hamlin, B. B. Kegley, R. Nilsson, B. E. B. Sandberg and M. Brechbiel, Bioconjugate Chem., 2002, 13, 1079–1092 CrossRef CAS PubMed.\n\nH. Shi, X. He, K. Wang, Y. Yuan, K. Deng, J. Chen and W. Tan, J. Nanomed. Nanotechnol., 2007, 3, 266–272 CrossRef CAS PubMed.\n\nM. Roederer, Conjugation of monoclonal antibodies, 2004, http://drmr.com/abcon/index.html.\n\nE. C. E. Butcher and I. L. I. Weissman, J. Immunol. Methods, 1979, 37, 97–108 CrossRef.\n\nA. M. Landel, Anal. Biochem., 1976, 73, 280–289 CrossRef CAS.\n\nD. S. Wilbur, M.-K. Chyan, H. Nakamae, Y. Chen, D. K. Hamlin, E. B. Santos, B. T. Kornblit and B. M. Sandmaier, Bioconjugate Chem., 2012, 23, 409–420 CrossRef CAS PubMed.\n\nP. R. Banks and D. M. Paquette, Bioconjugate Chem., 1995, 6, 447–458 CrossRef CAS.\n\nM. B. Smith and J. March, March's Advanced Organic Chemistry, John Wiley & Sons, 2007 Search PubMed.\n\nG. P. Smith, Bioconjugate Chem., 2006, 17, 501–506 CrossRef CAS PubMed.\n\nO. Mäkelä, Immunology, 1966, 10, 81–86 Search PubMed.\n\nJ. M. Becker, M. Wilchek and E. Katchalski, Proc. Natl. Acad. Sci. U. S. A., 1971, 68, 2604–2607 CrossRef CAS.\n\nM. Brinkley, Bioconjugate Chem., 1991, 3, 2–13 CrossRef.\n\nG. W. Anderson, J. E. Zimmerman and F. M. Callahan, J. Am. Chem. Soc., 1963, 85, 3039 CrossRef CAS.\n\nG. W. Anderson, F. M. Callahan and J. E. Zimmerman, J. Am. Chem. Soc., 1967, 89, 178 CrossRef CAS.\n\nW.-C. Yang, H. Mirzaei, X. Liu and F. E. Regnier, Anal. Chem., 2006, 78, 4702–4708 CrossRef CAS PubMed.\n\nF. E. Regnier and S. Julka, Proteomics, 2006, 6, 3968–3979 CrossRef CAS PubMed.\n\nY. Ishikawa, Y. Yamamoto, M. Otsubo, S. M. Theg and N. Tamura, Biochemistry, 2002, 41, 1972–1980 CrossRef CAS PubMed.\n\nB. Holmquist, S. Blumberg and B. L. Vallee, Biochemistry, 1976, 15, 4675–4680 CrossRef CAS.\n\nS. Blumberg and B. L. Vallee, Biochemistry, 1975, 14, 2410–2419 CrossRef CAS.\n\nM. D. Leavell, P. Novak, C. R. Behrens, J. S. Schoeniger and G. H. Kruppa, J. Am. Soc. Mass Spectrom., 2004, 15, 1604–1611 CrossRef CAS PubMed.\n\nP. Cuatrecasas and I. Parikh, Biochemistry, 1972, 11, 2291–2299 CrossRef CAS.\n\nB. T. Miller, T. J. Collins, G. T. Nagle and A. Kurosky, J. Biol. Chem., 1992, 267, 5060–5069 CAS.\n\nB. T. Miller and A. Kurosky, Biochem. Biophys. Res. Commun., 1993, 196, 461–467 CrossRef CAS PubMed.\n\nB. T. Miller, Biochem. Biophys. Res. Commun., 1996, 218, 377–382 CrossRef CAS PubMed.\n\nB. T. Miller, T. J. Collins, M. E. Rogers and A. Kurosky, Peptides, 1997, 18, 1585–1595 CrossRef CAS.\n\nS. Mädler, C. Bich, D. Touboul and R. Zenobi, J. Mass Spectrom., 2009, 44, 694–706 CrossRef PubMed.\n\nC. L. Swaim, J. B. Smith and D. L. Smith, Mikrochim. Acta, 2004, 15, 736–749 CAS.\n\nJ. S. Smith, B. T. Miller, S. L. Knock and A. Kurosky, Anal. Biochem., 1991, 197, 247–253 CrossRef CAS.\n\nS. Kalkhof and A. Sinz, Anal. Bioanal. Chem., 2008, 392, 305–312 CrossRef CAS.\n\nA. J. Lomant and G. Fairbanks, J. Mol. Biol., 1976, 104, 243–261 CrossRef CAS.\n\nJ. V. Staros, R. W. Wright and D. M. Swingle, Anal. Biochem., 1986, 156, 220–222 CrossRef CAS.\n\nN. Abello, H. A. M. Kerstjens, D. S. Postma and R. Bischoff, J. Proteome Res., 2007, 6, 4770–4776 CrossRef CAS PubMed.\n\nA. W. Yem, H. A. Zurcher-Neely, K. A. Richard, N. D. Staite, R. L. Heinrikson and M. R. Deibel, J. Biol. Chem., 1989, 264, 17691–17697 CAS.\n\nV. C. Lombardi and D. A. Schooley, Anal. Biochem., 2004, 331, 40–45 CrossRef CAS PubMed.\n\nM. Morpurgo, E. A. Bayer and M. Wilchek, J. Biochem. Biophys. Methods, 1999, 38, 17–28 CrossRef CAS.\n\nM. Cooper, A. Ebner, M. Briggs, M. Burrows, N. Gardner, R. Richardson and R. West, J. Fluoresc., 2004, 14, 145–150 CrossRef CAS.\n\nY. Deng, Z. Hou, L. Wang, C. Cherian, J. Wu, A. Gangjee and L. H. Matherly, Mol. Pharmacol., 2008, 73, 1274–1281 CrossRef CAS PubMed.\n\nD. Kahne and W. C. Still, J. Am. Chem. Soc., 1988, 110, 7529–7534 CrossRef CAS.\n\nJ. M. Becker and M. Wilchek, Biochim. Biophys. Acta, 1972, 264, 165–170 CrossRef CAS.\n\nM. Trester-Zedlitz, K. Kamada, S. K. Burley, D. Fenyö, B. T. Chait and T. W. Muir, J. Am. Chem. Soc., 2003, 125, 2416–2425 CrossRef CAS PubMed.\n\nR. Kluger and A. Alagic, Bioinorg. Chem., 2004, 32, 451–472 CrossRef CAS PubMed.\n\nM. A. Trakselis, S. C. Alley and F. T. Ishmael, Bioconjugate Chem., 2005, 16, 741–750 CrossRef CAS PubMed.\n\nX. Tang, G. R. Munske, W. F. Siems and J. E. Bruce, Anal. Chem., 2005, 77, 311–318 CrossRef CAS PubMed.\n\nJ. D. Chavez, N. L. Liu and J. E. Bruce, J. Proteome Res., 2011, 10, 1528–1537 CrossRef CAS PubMed.\n\nM. Q. Müller, F. Dreiocker, C. H. Ihling, M. Schäfer and A. Sinz, Anal. Chem., 2010, 82, 6958–6968 CrossRef PubMed.\n\nJ. W. Back, L. de Jong, A. O. Muijsers and C. G. de Koster, J. Mol. Biol., 2003, 331, 303–313 CrossRef CAS.\n\nM. M. Young, N. Tang, J. C. Hempel, C. M. Oshiro, E. W. Taylor, I. D. Kuntz, B. W. Gibson and G. Dollinger, Proc. Natl. Acad. Sci. U. S. A., 2000, 97, 5802–5806 CrossRef CAS PubMed.\n\nS. Avrameas, Immunochemistry, 1969, 6, 43–52 CrossRef CAS.\n\nB. F. Erlanger, Pharmacol. Rev., 1973, 25, 271–280 CAS.\n\nM. C. Garnett, Adv. Drug Delivery Rev., 2001, 53, 171–216 CrossRef CAS.\n\nD. M. Schulz, C. Ihling, G. M. Clore and A. Sinz, Biochemistry, 2004, 43, 4703–4715 CrossRef CAS PubMed.\n\nS. Takeda, S. Tsukiji, H. Ueda and T. Nagamune, Org. Biomol. Chem., 2008, 6, 2187–2194 CAS.\n\nN. K. Damle, Nat. Biotechnol., 2008, 26, 884–885 CrossRef CAS PubMed.\n\nS. C. Alley, N. M. Okeley and P. D. Senter, Curr. Opin. Chem. Biol., 2010, 14, 529–537 CrossRef CAS PubMed.\n\nS. Webb, Nat. Biotechnol., 2011, 29, 297–298 CrossRef CAS PubMed.\n\nW.-D. Janthur, N. Cantoni and C. Mamot, Int. J. Mol. Sci., 2012, 13, 16020–16045 CrossRef CAS PubMed.\n\nR. S. Zolot, S. Basu and R. P. Million, Nat. Rev. Drug Discovery, 2013, 12, 259–260 CrossRef CAS PubMed.\n\nP. M. Abdella, P. K. Smith and G. P. Royer, Biochem. Biophys. Res. Commun., 1979, 87, 734–742 CrossRef CAS.\n\nD. A. Zarling, A. Watson and F. H. Bach, J. Immunol., 1980, 124, 913–920 CAS.\n\nR. J. Smith, R. A. Capaldi, D. Muchmore and F. Dahlquist, Biochemistry, 1978, 17, 3719–3723 CrossRef CAS.\n\nR. Reents, D. A. Jeyaraj and H. Waldmann, Drug Discovery Today, 2002, 7, 71–76 CrossRef CAS.\n\nG. Leriche, L. Chisholm and A. Wagner, Bioorg. Med. Chem., 2012, 20, 571–582 CrossRef CAS PubMed.\n\nY. Jin Lee, Mol. BioSyst., 2008, 4, 816–823 RSC.\n\nA. Sinz, S. Kalkhof and C. Ihling, J. Am. Soc. Mass Spectrom., 2005, 16, 1921–1931 CrossRef CAS PubMed.\n\nM. Wilchek and E. A. Bayer, Methods Enzymol., 1990, 184, 123–138 CAS.\n\nE. A. Bayer and M. Wilchek, Methods Enzymol., 1990, 184, 138–160 CAS.\n\nX. Chen, K. Muthoosamy, A. Pfisterer, B. Neumann and T. Weil, Bioconjugate Chem., 2012, 23, 500–508 CrossRef CAS PubMed.\n\nE. R. Goldman, E. D. Balighian, H. Mattoussi, M. K. Kuno, J. M. Mauro, P. T. Tran and G. P. Anderson, J. Am. Chem. Soc., 2002, 124, 6378–6382 CrossRef CAS PubMed.\n\nM. R. Lockett, M. F. Phillips, J. L. Jarecki, D. Peelen and L. M. Smith, Langmuir, 2008, 24, 69–75 CrossRef CAS PubMed.\n\nM. Yang, R. L. Teeuwen, M. Giesbers, J. Baggerman, A. Arafat, F. A. de Wolf, J. C. van Hest and H. Zuilhof, Langmuir, 2008, 24, 7931–7938 CrossRef CAS PubMed.\n\nA. E. Bolton and W. M. Hunter, Biochem. J., 1973, 133, 529–539 CAS.\n\nJ. J. Langone, Methods Enzymol., 1980, 70, 221–247 CAS.\n\nP. Anderson, Methods Enzymol., 1986, 119, 281–283 CAS.\n\nM. Glaser, V. A. Carroll, D. R. Collingridge, E. O. Aboagye, P. Price, R. Bicknell, A. L. Harris, S. K. Luthra and F. Brady, J. Labelled Compd. Radiopharm., 2002, 45, 1077–1090 CrossRef CAS PubMed.\n\nJ. Russell, J. A. O'Donoghue, R. Finn, J. Koziorowski, S. Ruan, J. L. Humm and C. C. Ling, J. Nucl. Med., 2002, 43, 671–677 CAS.\n\nD. R. Collingridge, V. A. Carroll, M. Glaser and E. O. Aboagye, Cancer Res., 2002, 62, 5912–5919 CAS.\n\nJ. J. Park, T. S. Lee, J. H. Kang, R. Song and G. J. Cheon, Appl. Radiat. Isot., 2011, 69, 56–62 CrossRef CAS PubMed.\n\nT. H. Ji and I. Ji, Anal. Biochem., 1982, 121, 286–289 CrossRef CAS.\n\nP. L. Ross, Mol. Cell. Proteomics, 2004, 3, 1154–1169 CAS.\n\nL. R. Zieske, J. Exp. Bot., 2006, 57, 1501–1508 CrossRef CAS PubMed.\n\nK. Aggarwal, L. H. Choe and K. H. Lee, Briefings Funct. Genomics Proteomics, 2006, 5, 112–120 CrossRef CAS PubMed.\n\nH. Mirzaei and F. Regnier, Anal. Chem., 2006, 78, 4175–4183 CrossRef CAS PubMed.\n\nR. F. Borch, M. D. Bernstein and H. D. Durst, J. Am. Chem. Soc., 1971, 93, 2897–2904 CrossRef CAS.\n\nG. R. Gray, Arch. Biochem. Biophys., 1974, 163, 426–428 CrossRef CAS.\n\nJ. C. Gildersleeve, O. Oyelaran, J. T. Simpson and B. Allred, Bioconjugate Chem., 2008, 19, 1485–1490 CrossRef CAS PubMed.\n\nB. A. Schwartz and G. R. Gray, Arch. Biochem. Biophys., 1977, 181, 542–549 CrossRef CAS.\n\nR. T. Lee and Y. C. Lee, Biochemistry, 1980, 19, 156–163 CrossRef CAS.\n\nT. Freire, S. Bay, S. Vichier-Guerre, R. Lo-Man and C. Leclerc, Mini-Rev. Med. Chem., 2006, 6, 1357–1373 CrossRef CAS.\n\nS. Y. Wong, Curr. Opin. Struct. Biol., 1995, 5, 599–604 CrossRef CAS.\n\nP. H. Seeberger and D. B. Werz, Nature, 2007, 446, 1046–1051 CrossRef CAS PubMed.\n\nL. Cipolla, F. Peri and C. Airoldi, Anti-Cancer Agents Med. Chem., 2008, 8, 92–121 CrossRef CAS.\n\nS. B. Oppenheimer, M. Alvarez and J. Nnoli, Acta Histochem., 2008, 110, 6–13 CrossRef CAS PubMed.\n\nD. C. Tahmassebi and T. Sasaki, J. Org. Chem., 1998, 63, 728–731 CrossRef CAS PubMed.\n\nM. D. Bentley, M. J. Roberts and J. M. Harris, J. Pharm. Sci., 1998, 87, 1446–1449 CrossRef CAS PubMed.\n\nL. Tao, G. Mantovani, F. Lecolley and D. M. Haddleton, J. Am. Chem. Soc., 2004, 126, 13220–13221 CrossRef CAS PubMed.\n\nR. Mallik, T. Jiang and D. S. Hage, Anal. Chem., 2004, 76, 7013–7022 CrossRef CAS PubMed.\n\nR. Tripathi, S. Verma, J. Pandey and V. Tiwari, Curr. Org. Chem., 2008, 12, 1093–1115 CrossRef CAS.\n\nJ. McFarland and M. Francis, J. Am. Chem. Soc., 2005, 127, 13490–13491 CrossRef CAS PubMed.\n\nG. Weber, Biochem. J., 1952, 51, 155–167 CAS.\n\nB. S. Hartley and V. Massey, Biochim. Biophys. Acta, 1956, 21, 58–70 CrossRef CAS.\n\nW. R. Gray, Methods Enzymol., 1967, 11, 469–475 CAS.\n\nC. Lefevre, H. C. Kang, R. P. Haugland, N. Malekzadeh, S. Arttamangkul and R. P. Haugland, Bioconjugate Chem., 1996, 7, 482–489 CrossRef CAS PubMed.\n\nJ. A. J. Titus, R. R. Haugland, S. O. S. Sharrow and D. M. D. Segal, J. Immunol. Methods, 1981, 50, 193–204 CrossRef.\n\nN. Seiler, Methods Biochem. Anal., 1970, 18, 259–337 CAS.\n\nMethods in Molecular Biology, Humana Press, Totowa, NJ, 2009, vol. 588, pp. 43–48 Search PubMed.\n\nW. R. Gray, Methods Enzymol., 1967, 11, 139–151 CAS.\n\nC. Gros and B. Labouesse, Eur. J. Biochem., 1969, 7, 463–470 CrossRef CAS PubMed.\n\nR. E. Boyle, J. Org. Chem., 1966, 31, 3880–3882 CrossRef CAS.\n\nJ. K. Lin and J. Y. Chang, Anal. Chem., 1975, 47, 1634–1638 CrossRef CAS.\n\nR. A. Evangelista, A. Pollak, B. Allore, A. F. Templeton, R. C. Morton and E. P. Diamandis, Clin. Biochem., 1988, 21, 173–178 CrossRef CAS.\n\nA. Andreoni, G. Bottiroli, A. Colasanti, M. C. Giangarè, P. Riccio, G. Roberti and P. Vaghi, J. Biochem. Biophys. Methods, 1994, 29, 157–172 CrossRef CAS.\n\nB. M. Gorovits and P. M. Horowitz, J. Biol. Chem., 1995, 270, 13057–13062 CrossRef CAS PubMed.\n\nD. J. Herzig, A. W. Rees and R. A. Day, Biopolymers, 1964, 2, 349–360 CrossRef CAS PubMed.\n\nA. M. Gold, Biochemistry, 1965, 4, 897–901 CrossRef CAS.\n\nR. S. Tipson, J. Org. Chem., 1944, 9, 235–241 CrossRef CAS.\n\nR. K. Crossland, W. E. Wells and V. J. Shiner, J. Am. Chem. Soc., 1971, 93, 4217–4219 CrossRef CAS.\n\nK. Nilsson and K. Mosbach, Biochem. Biophys. Res. Commun., 1981, 102, 449–457 CrossRef CAS.\n\nZ. Ma, C. Gao, J. Ji and J. Shen, Eur. Polym. J., 2002, 38, 2279–2284 CrossRef CAS.\n\nK. Pugdee, Y. Shibata, N. Yamamichi, H. Tsutsumi, M. Yoshinari, Y. Abiko and T. Hayakawa, Dent. Mater. J., 2007, 26, 647–655 CrossRef CAS.\n\nC. Delgado, J. N. Patel, G. E. Francis and D. Fisher, Biotechnol. Bioprocess Eng., 1990, 12, 119–128 CAS.\n\nG. E. Francis, D. Fisher, C. Delgado, F. Malik, A. Gardiner and D. Neale, Int. J. Hematol., 1998, 68, 1–18 CrossRef CAS.\n\nM. J. Roberts, M. D. Bentley and J. M. Harris, Adv. Drug Delivery Rev., 2012, 64, 116–127 CrossRef PubMed.\n\nH.-J. Gais and S. Ruppert, Tetrahedron Lett., 1995, 36, 3837–3838 CrossRef CAS.\n\nH. T. F. Sanger, Biochem. J., 1951, 49, 481–490 Search PubMed.\n\nH. N. Eisen, S. Belman and M. E. Carsten, J. Am. Chem. Soc., 1953, 75, 4583–4585 CrossRef CAS.\n\nS. Shaltiel, Biochem. Biophys. Res. Commun., 1967, 29, 178–183 CrossRef CAS.\n\nK. Imai and Y. Watanabe, Anal. Chim. Acta, 1981, 130, 377–383 CrossRef CAS.\n\nA. A. Elbashir and F. Suliman, Appl. Spectrosc., 2011, 46, 222–241 CrossRef PubMed.\n\nS. Uchiyama, T. Santa, N. Okiyama, T. Fukushima and K. Imai, Biomed. Chromatogr., 2001, 15, 295–318 CrossRef CAS PubMed.\n\nT. Santa, T. Fukushima, T. Ichibangase and K. Imai, Biomed. Chromatogr., 2008, 22, 343–353 CrossRef CAS PubMed.\n\nP. Smialowski and D. Frishman, in Data Mining Techniques for the Life Sciences, Humana Press, 2010, vol. 609, pp. 385–400, DOI:10.1007/978-1-60327-241-4_22.\n\nD. A. Sutton, S. E. Drewes and U. Welz, Biochem. J., 1972, 130, 589–595 CAS.\n\nM. Lesniak, J. Gliemann, J. Roth, B. R. Easter, D. A. Sutton and S. E. Drewes, Hoppe-Seyler's Z. Physiol. Chem., 1979, 360, 467–472 CrossRef CAS.\n\nD. A. Sutton, B. R. Easter and S. E. Drewes, Hoppe-Seyler's Z. Physiol. Chem., 1976, 357, 971–976 CrossRef CAS.\n\nG. Losse and G. Mützler, Z. Chem., 1981, 21, 394–403 CrossRef CAS PubMed.\n\nD. L. Ladd and R. A. Snow, Anal. Biochem., 1993, 210, 258–261 CrossRef CAS PubMed.\n\nM. J. Hunter and M. L. Ludwig, J. Am. Chem. Soc., 1962, 84, 3491–3504 CrossRef CAS.\n\nR. R. Traut, A. Bollen, T.-T. Sun, J. W. B. Hershey, J. Sundberg and L. R. Pierce, Biochemistry, 1973, 12, 3266–3273 CrossRef CAS.\n\nM. Nomura, Science, 1973, 179, 864–873 CAS.\n\nL. Wofsy and S. J. Singer, Biochemistry, 1963, 2, 104–116 CrossRef CAS.\n\nH. J. H. Schramm, Hoppe-Seyler's Z. Physiol. Chem., 1975, 356, 1375–1379 CrossRef CAS.\n\nH. Bozler, K. D. Jany and G. Pfleiderer, Biochim. Biophys. Acta, 1983, 749, 238–243 CrossRef CAS.\n\nY. C. Lee, C. P. Stowell and M. J. Krantz, Biochemistry, 1976, 15, 3956–3963 CrossRef CAS.\n\nR. R. Mehlhorn, M. M. Swanson, L. L. Packer and P. P. Smith, Arch. Biochem. Biophys., 1980, 204, 471–476 CrossRef CAS.\n\nJ. B. J. Denny and R. M. R. Roberts, J. Biol. Chem., 1982, 257, 2460–2468 CAS.\n\nF. T. Wood, M. M. Wu and J. C. Gerhart, Anal. Biochem., 1975, 69, 339–349 CrossRef CAS.\n\nD. E. Wright, EP0539167, 1993, http://patentscope.wipo.int/search/en/detail.jsf?docId=EP12397580.\n\nK. Ampon and G. E. Means, Biotechnol. Bioeng., 1988, 32, 689–697 CrossRef CAS PubMed.\n\nJ. I. Gavrilyuk, U. Wuellner and C. F. Barbas, Bioorg. Med. Chem. Lett., 2009, 19, 1421–1424 CrossRef CAS PubMed.\n\nJ. I. Gavrilyuk, U. Wuellner, S. Salahuddin, R. K. Goswami, S. C. Sinha and C. F. Barbas III, Bioorg. Med. Chem. Lett., 2009, 19, 3716–3720 CrossRef CAS PubMed.\n\nL. F. Tietze, M. Arlt, M. Beller, K.-H. Glüsenkamp, E. Jähde and M. F. Rajewsky, Chem. Ber., 1991, 124, 1215–1221 CrossRef CAS PubMed.\n\nL. F. Tietze, C. Schroeter, S. Gabius, U. Brinck, A. Goerlach-Graw and H. J. Gabius, Bioconjugate Chem., 1991, 2, 148–153 CrossRef CAS.\n\nF. Wurm, C. Dingels, H. Frey and H.-A. Klok, Biomacromolecules, 2012, 13, 1161–1171 CrossRef CAS PubMed.\n\nF. Wurm, T. Steinbach and H.-A. Klok, Chem. Commun., 2013, 49, 7815–7817 RSC.\n\nD. Blakeslee and M. G. Baines, J. Immunol. Methods, 1976, 13, 305–320 CrossRef CAS.\n\nD. Blakeslee, J. Immunol. Methods, 1977, 17, 361–364 CrossRef CAS.\n\nA. Abuchowski, T. Es, N. C. Palczuk and F. F. Davis, J. Biol. Chem., 1977, 252, 3578–3581 CAS.\n\nA. Abuchowski, J. R. McCoy, N. C. Palczuk, T. Es and F. F. Davis, J. Biol. Chem., 1977, 252, 3582–3586 CAS.\n\nA. Matsushima, Chem. Lett., 1980, 773–776 CrossRef CAS.\n\nS. S. Arpicco, F. F. Dosio, A. A. Bolognesi, C. C. Lubelli, P. P. Brusa, B. B. Stella, M. M. Ceruti and L. L. Cattel, Bioconjugate Chem., 2002, 13, 757–765 CrossRef CAS PubMed.\n\nY. Ikeda, J. Katamachi, H. Kawasaki and Y. Nagasaki, Bioconjugate Chem., 2013, 24, 1824–1827 CrossRef CAS PubMed.\n\nF. R. Gurd, Methods Enzymol., 1971, 25, 424–438 Search PubMed.\n\nI. Forristal, J. Sulfur Chem., 2005, 26, 163–185 CrossRef CAS PubMed.\n\nE. Valero, S. Tambalo, P. Marzola, M. Ortega-Muñoz, F. J. Lopez-Jaramillo, F. Santoyo-Gonzalez, J. de Dios López, J. J. Delgado, J. J. Calvino, R. Cuesta, J. M. Domínguez-Vera and N. Gálvez, J. Am. Chem. Soc., 2011, 133, 4889–4895 CrossRef CAS PubMed.\n\nA. Megia-Fernandez, F. Hernandez-Mateo and F. Santoyo-Gonzalez, Org. Biomol. Chem., 2013, 11, 2586–2596 CAS.\n\nR. L. Lundblad, Chemical Reagents for Protein Modification, CRC Press, 3rd edn, 2010 Search PubMed.\n\nM.-P. Brun and L. Gauzy-Lazo, Antibody–Drug conjugates, 2013, 1045, 173–187 Search PubMed.\n\nS. Mädler, M. Seitz, J. Robinson and R. Zenobi, Mikrochim. Acta, 2010, 21, 1775–1783 Search PubMed.\n\nB. T. Miller, M. E. Rogers, J. S. Smith and A. Kurosky, Anal. Biochem., 1994, 219, 240–248 CrossRef CAS PubMed.\n\nS. Mädler, S. Gschwind and R. Zenobi, Role of arginine in chemical cross-linking with N-hydroxysuccinimide esters, 2010, vol. 398 Search PubMed.\n\nF. Brotzel and H. Mayr, Org. Biomol. Chem., 2007, 5, 3814–3820 CAS.\n\nD. Gilis, S. Massar, N. J. Cerf and M. Rooman, Genome Biol., 2001, 2, 1–12 CrossRef.\n\nM. N. Fodje and S. Al-Karadaghi, Protein Eng., 2002, 15, 353–358 CrossRef CAS PubMed.\n\nS. J. Sirk, T. Olafsen, B. Barat, K. B. Bauer and A. M. Wu, Bioconjugate Chem., 2008, 19, 2527–2534 CrossRef CAS PubMed.\n\nJ. J. Gorman, G. L. Corino and S. J. Mitchell, Eur. J. Biochem., 1987, 168, 169–179 CrossRef CAS PubMed.\n\nJ. A. Burns, J. C. Butler, J. Moran and G. M. Whitesides, J. Org. Chem., 1991, 56, 2648–2650 CrossRef CAS.\n\nE. B. Getz, M. Xiao, T. Chakrabarty, R. Cooke and P. R. Selvin, Anal. Biochem., 1999, 273, 73–80 CrossRef CAS PubMed.\n\nR. E. Hansen and J. R. Winther, Anal. Biochem., 2009, 394, 147–158 CrossRef CAS PubMed.\n\nK. Tyagarajan, E. Pretzer and J. E. Wiktorowicz, Electrophoresis, 2003, 24, 2348–2358 CrossRef CAS PubMed.\n\nD. E. Shafer, J. K. Inman and A. Lees, Anal. Biochem., 2000, 282, 161–164 CrossRef CAS PubMed.\n\nD. R. Goddard and L. Michaelis, J. Biol. Chem., 1935, 112, 361–371 CAS.\n\nN. Lundell and T. Schreitmüller, Anal. Biochem., 1999, 266, 31–47 CrossRef CAS PubMed.\n\nF. R. Gurd, Methods Enzymol., 1972, 25, 424–438 CAS.\n\nM. L. Nielsen, M. Vermeulen, T. Bonaldi, J. Cox, L. Moroder and M. Mann, Nat. Methods, 2008, 5, 459–460 CrossRef CAS PubMed.\n\nB. I. Gerwin, J. Biol. Chem., 1967, 242, 451–456 CAS.\n\nJ. R. Kim, H. W. Yoon, K. S. Kwon, S. R. Lee and S. G. Rhee, Anal. Biochem., 2000, 283, 214–221 CrossRef CAS PubMed.\n\nN. J. Davis and S. L. Flitsch, Tetrahedron Lett., 1991, 32, 6793–6796 CrossRef CAS.\n\nD. Macmillan, R. Bill, K. Sage, D. Fern and S. Flitsch, Chem. Biol., 2001, 8, 133–145 CrossRef CAS.\n\nR. S. Swanwick, A. M. Daines, L.-H. Tey, S. L. Flitsch and R. K. Allemann, ChemBioChem, 2005, 6, 1338–1340 CrossRef CAS PubMed.\n\nJ. F. Mackworth, Biochem. J., 1948, 42, 82–90 CAS.\n\nP. I. Clark and G. Lowe, J. Am. Chem. Soc., 1977, 24, 923–924 Search PubMed.\n\nP. I. Clark and G. Lowe, Eur. J. Biochem., 1978, 84, 293–299 CrossRef CAS PubMed.\n\nR. W. Furlanetto and E. T. Kaiser, J. Am. Chem. Soc., 1970, 92, 6980–6982 CrossRef CAS.\n\nR. W. Furlanetto, M. Mochizuki and E. T. Kaiser, Biochem. Biophys. Res. Commun., 1974, 58, 192–196 CrossRef CAS.\n\nK. J. Schwartz, Y. Nakagawa and E. T. Kaiser, J. Am. Chem. Soc., 1976, 98, 6369–6378 CrossRef CAS.\n\nE. Kaiser and D. Lawrence, Science, 1984, 226, 505–511 CAS.\n\nE. Friedmann and D. H. Marrian, Br. J. Pharmacol., 1949, 4, 105–108 CrossRef CAS PubMed.\n\nE. Friedmann, Biochim. Biophys. Acta, 1952, 9, 65–75 CrossRef CAS.\n\nT. Kajfež, B. Kamenar, V. Piližota and D. Fleš, Croat. Chem. Acta, 2003, 76, 343–346 Search PubMed.\n\nS. G. Bodige, M. A. Méndez-Rojas and W. H. Watson, J. Chem. Crystallogr., 1999, 29, 57–66 CrossRef CAS.\n\nD. G. Smyth, O. O. Blumenfeld and W. Konigsberg, Biochem. J., 1964, 91, 589–595 CAS.\n\nR. D. Brown and K. S. Matthews, J. Biol. Chem., 1979, 254, 5128–5134 CAS.\n\nY. Ishii and S. S. Lehrer, Biophys. J., 1986, 50, 75–80 CrossRef CAS.\n\nC.-W. Wu, L. R. Yarbrough and F. Y. Wu, Biochemistry, 1976, 15, 2863–2868 CrossRef CAS.\n\nT. Climent, R. González-Luque and M. Merchán, J. Phys. Chem. A, 2003, 107, 6995–7003 CrossRef CAS.\n\nP. Schelté, C. Boeckler, B. Frisch and F. Schuber, Bioconjugate Chem., 2000, 11, 118–123 CrossRef PubMed.\n\nS. Yoshitake, Y. Yamada, E. Ishikawa and R. Masseyeff, Eur. J. Biochem., 1979, 101, 395–399 CrossRef CAS PubMed.\n\nS. Yoshitake, M. Imagawa, E. Ishikawa, Y. Niitsu, I. Urushizaki, M. Nishiura, R. Kanazawa, H. Kurosaki, S. Tachibana and N. Nakazawa, J. Biochem., 1982, 92, 1413–1424 CAS.\n\nS. Hashida, M. Imagawa, S. Inoue, K. H. Ruan and E. Ishikawa, J. Appl. Biochem., 1984, 6, 56–63 CAS.\n\nS. S. Ghosh, P. M. Kao, A. W. McCue and H. L. Chappelle, Bioconjugate Chem., 1990, 1, 71–76 CrossRef CAS.\n\nN. Dickgreber, P. Stoitzner, Y. Bai, K. M. Price, K. J. Farrand, K. Manning, C. E. Angel, P. R. Dunbar, F. Ronchese, J. D. Fraser, B. T. Bäckström and I. F. Hermans, J. Immunol., 2009, 182, 1260–1269 CrossRef CAS.\n\nT. Hu and Z. Su, Biotechnol. Lett., 2002, 24, 275–278 CrossRef CAS.\n\nK. Kafi, D. J. Betting, R. E. Yamada, M. Bacica, K. K. Steward and J. M. Timmerman, Mol. Immunol., 2009, 46, 448–456 CrossRef CAS PubMed.\n\nG. K. Ehrlich, H. Michel, T. Truitt and W. Riboulet, Bioconjugate Chem., 2013, 24, 2015–2024 CrossRef CAS PubMed.\n\nF. Kratz, A. Warnecke, K. Scheuermann, C. Stockmar, J. Schwab, P. Lazar, P. Drückes, N. Esser, J. Drevs, D. Rognan, C. Bissantz, C. Hinderling, G. Folkers, I. Fichtner and C. Unger, J. Med. Chem., 2002, 45, 5523–5533 CrossRef CAS PubMed.\n\nA. Warnecke, I. Fichtner, G. Sass and F. Kratz, Arch. Pharm., 2007, 340, 389–395 CrossRef CAS PubMed.\n\nV. Kersemans, B. Cornelissen, M. D. Minden, J. Brandwein and R. M. Reilly, J. Nucl. Med., 2008, 49, 1546–1554 CrossRef CAS PubMed.\n\nD. J. Betting, K. Kafi, A. Abdollahi-Fard, S. A. Hurvitz and J. M. Timmerman, J. Immunol., 2008, 181, 4131–4140 CrossRef CAS.\n\nA. Alisio, J. Biol. Chem., 2004, 279, 26540–26545 CrossRef CAS PubMed.\n\nL. Giron-Monzon, J. Biol. Chem., 2004, 279, 49338–49345 CrossRef CAS PubMed.\n\nN. S. Green, E. Reisler and K. N. Houk, Protein Sci., 2008, 10, 1293–1304 CrossRef PubMed.\n\nF. T. Ishmael, M. A. Trakselis and S. J. Benkovic, J. Biol. Chem., 2003, 278, 3145–3152 CrossRef CAS PubMed.\n\nO. V. Kovalenko, X. Yang, T. V. Kolesnikova and M. E. Hemler, Biochem. J., 2004, 377, 407–417 CrossRef CAS PubMed.\n\nY. K. Kwon, J. Cell Biol., 2003, 163, 375–384 CrossRef CAS PubMed.\n\nM. A. Stalteri and S. J. Mather, Bioconjugate Chem., 1995, 6, 179–186 CrossRef CAS.\n\nE. E. Leary Swan, K. C. Popat and T. A. Desai, Biomaterials, 2005, 26, 1969–1976 CrossRef CAS PubMed.\n\nA. Misra and P. Dwivedi, Anal. Biochem., 2007, 369, 248–255 CrossRef CAS PubMed.\n\nG. Elia, Curr. Protein Pept. Sci., 2010 Search PubMed , ch. 3. Unit 3.6.\n\nY. Oda, T. Nagasu and B. T. Chait, Nat. Biotechnol., 2001, 19, 379–382 CrossRef CAS PubMed.\n\nS. Khurana, M. Kennedy, L. R. King and H. Golding, J. Virol., 2005, 79, 6791–6800 CrossRef CAS PubMed.\n\nH. Golding, J. Biol. Chem., 2005, 280, 29570–29577 CrossRef CAS PubMed.\n\nF.-U. Gast, I. Franke, G. Meiss and A. Pingoud, J. Biotechnol., 2001, 87, 131–141 CrossRef CAS.\n\nI. H. Cho, E. H. Paek, H. Lee, J. W. Choi and S. H. Paek, Biotechnol. Bioprocess Eng., 2004, 9, 112–117 CrossRef CAS.\n\nG. Y. Kang, G. Y. Han, J. Y. Kang, I.-H. Cho, H.-H. Park, S.-H. Paek and T. S. Kim, Sens. Actuators, B, 2006, 117, 332–338 CrossRef CAS PubMed.\n\nI.-H. Cho, E.-H. Paek, H. Lee, J. Y. Kang, T. S. Kim and S.-H. Paek, Anal. Biochem., 2007, 365, 14–23 CrossRef CAS PubMed.\n\nA. Pompella, S. Dominici, C. Cambiaggi, J. Frank and H. K. Biesalski, Methods Mol. Biol., 2002, 196, 305–312 CAS.\n\nJ. M. Kuiper, R. Pluta, W. H. C. Huibers, F. Fusetti, E. R. Geertsma and B. Poolman, Protein Sci., 2009, 18, 1033–1041 CrossRef CAS PubMed.\n\nX. Chen, Y. Zhou, X. Peng and J. Yoon, Chem. Soc. Rev., 2010, 39, 2120 RSC.\n\nY. Zhang, V. S. Bhatt, G. Sun, P. G. Wang and A. F. Palmer, Bioconjugate Chem., 2008, 19, 2221–2230 CrossRef CAS PubMed.\n\nS. Ahlgren, A. Orlova, D. Rosik, M. Sandström, A. Sjöberg, B. Baastrup, O. Widmark, G. Fant, J. Feldwisch and V. Tolmachev, Bioconjugate Chem., 2008, 19, 235–243 CrossRef CAS PubMed.\n\nC. A. Boswell, J. Marik, M. J. Elowson, N. A. Reyes, S. Ulufatu, D. Bumbaca, V. Yip, E. E. Mundo, N. Majidy, M. Van Hoy, S. N. Goriparthi, A. Trias, H. S. Gill, S. P. Williams, J. R. Junutula, P. J. Fielder and L. A. Khawli, J. Med. Chem., 2013, 56, 9418–9426 CrossRef CAS PubMed.\n\nM. K. Han, P. Lin, D. Paek, J. J. Harvey, E. Fuior and J. R. Knutson, Biochemistry, 2002, 41, 3468–3476 CrossRef CAS PubMed.\n\nJ. M. West, J. Biol. Chem., 2003, 279, 945–951 CrossRef PubMed.\n\nF. Fernandes, L. M. S. Loura, R. Koehorst, R. B. Spruijt, M. A. Hemminga, A. Fedorov and M. Prieto, Biophys. J., 2004, 87, 344–352 CrossRef CAS PubMed.\n\nT. G. Nishino, K. Kitano, K. Kojima, T. Ogishima, A. Ito and S. Kitada, J. Biochem., 2007, 141, 889–895 CrossRef CAS PubMed.\n\nS. K. Wright and R. E. Viola, Anal. Biochem., 1998, 265, 8–14 CrossRef CAS PubMed.\n\nP. G. Mastroberardino, A. L. Orr, X. Hu, H. M. Na and J. T. Greenamyre, Free Radical Biol. Med., 2008, 45, 971–981 CrossRef CAS PubMed.\n\nG. Mantovani, F. Lecolley, L. Tao, D. M. Haddleton, J. Clerx, J. J. L. M. Cornelissen and K. Velonia, J. Am. Chem. Soc., 2005, 127, 2966–2973 CrossRef CAS PubMed.\n\nS. Matsui and H. Aida, J. Chem. Soc., Perkin Trans. 2, 1978, 1277–1280 RSC.\n\nJ. Kalia and R. T. Raines, Bioorg. Med. Chem. Lett., 2007, 17, 6286–6289 CrossRef CAS PubMed.\n\nL. M. Tedaldi, M. E. B. Smith, R. I. Nathani and J. R. Baker, Chem. Commun., 2009, 6583–6585 RSC.\n\nD. D. Roberts, S. D. Lewis, D. P. Ballou, S. T. Olson and J. A. Shafer, Biochemistry, 1986, 25, 5595–5601 CrossRef CAS.\n\nM. E. B. Smith, F. F. Schumacher, C. P. Ryan, L. M. Tedaldi, D. Papaioannou, G. Waksman, S. Caddick and J. R. Baker, J. Am. Chem. Soc., 2010, 132, 1960–1965 CrossRef CAS PubMed.\n\nC. P. Ryan, M. E. B. Smith, F. F. Schumacher, D. Grohmann, D. Papaioannou, G. Waksman, F. Werner, J. R. Baker and S. Caddick, Chem. Commun., 2011, 47, 5452–5454 RSC.\n\nL. Castañeda, A. Maruani, F. F. Schumacher, E. Miranda, V. Chudasama, K. A. Chester, J. R. Baker, M. E. B. Smith and S. Caddick, Chem. Commun., 2013, 49, 8187–8189 RSC.\n\nJ. Porath and R. Axén, Methods Enzymol., 1976, 44, 19–45 CAS.\n\nM. S. Masri and M. Friedman, J. Protein Chem., 1988, 7, 49–54 CrossRef CAS.\n\nG. Houen and O. M. Jensen, J. Immunol. Methods, 1995, 181, 187–200 CrossRef CAS.\n\nM. Morpurgo, F. M. Veronese, D. Kachensky and J. M. Harris, Bioconjugate Chem., 1996, 7, 363–368 CrossRef CAS PubMed.\n\nD. C. Meadows and J. Gervay-Hague, Med. Res. Rev., 2006, 26, 793–814 CrossRef CAS PubMed.\n\nP. Bailon and C.-Y. Won, Expert Opin. Drug Delivery, 2009, 6, 1–16 CrossRef CAS PubMed.\n\nF. Rusmini, Z. Zhong and J. Feijen, Biomacromolecules, 2007, 8, 1775–1789 CrossRef CAS PubMed.\n\nM. Ortega-Muñoz, J. Morales-Sanfrutos, A. Megia-Fernandez, F. J. Lopez-Jaramillo, F. Hernandez-Mateo and F. Santoyo-Gonzalez, J. Mater. Chem., 2010, 20, 7189–7196 RSC.\n\nJ. Morales-Sanfrutos, J. Lopez-Jaramillo, M. Ortega-Muñoz, A. Megia-Fernandez, F. Perez-Balderas, F. Hernandez-Mateo and F. Santoyo-Gonzalez, Org. Biomol. Chem., 2010, 8, 667–675 CAS.\n\nF. J. Lopez-Jaramillo, M. Ortega-Muñoz, A. Megia-Fernandez, F. Hernandez-Mateo and F. Santoyo-Gonzalez, Bioconjugate Chem., 2012, 23, 846–855 CrossRef CAS PubMed.\n\nL. Li, S.-W. Tsai, A.-L. Anderson, D. A. Keire, A. A. Raubitschek and J. E. Shively, Bioconjugate Chem., 2002, 13, 110–115 CrossRef CAS PubMed.\n\nJ. Morales-Sanfrutos, F. J. Lopez-Jaramillo, F. Hernandez-Mateo and F. Santoyo-Gonzalez, J. Org. Chem., 2010, 75, 4039–4047 CrossRef CAS PubMed.\n\nF. Lopez-Jaramillo, F. Hernandez Mateo, F. Santoyo Gonzalez and E. Leung, Integr. Proteom., 2012, 16, 301–326 Search PubMed.\n\nH. Ovaa, et al. , Angew. Chem., Int. Ed., 2003, 42, 3626–3629 CrossRef CAS PubMed.\n\nT. Posner, Chem. Ber., 1905, 38, 646–657 CrossRef PubMed.\n\nC. E. Hoyle and C. N. Bowman, Angew. Chem., Int. Ed., 2010, 49, 1540–1573 CrossRef CAS PubMed.\n\nA. Dondoni and A. Marra, Chem. Soc. Rev., 2012, 41, 573–586 RSC.\n\nN. Floyd, B. Vijayakrishnan, J. R. Koeppe and B. G. Davis, Angew. Chem., Int. Ed., 2009, 121, 7938–7942 CrossRef PubMed.\n\nA. Dondoni, A. Massi, P. Nanni and A. Roda, Chem. – Eur. J., 2009, 15, 11444–11449 CrossRef CAS PubMed.\n\nL.-Z. Wu, Y.-B. Sheng, J.-B. Xie and W. Wang, J. Mol. Struct., 2008, 882, 101–106 CrossRef CAS PubMed.\n\nK. C. A. Garber and E. E. Carlson, ACS Chem. Biol., 2013, 8, 1671–1676 CrossRef CAS PubMed.\n\nR. M. Stolz and B. H. Northrop, J. Org. Chem., 2013, 78, 8105–8116 CrossRef CAS PubMed.\n\nL. Markey, S. Giordani and E. M. Scanlan, J. Org. Chem., 2013, 78, 4270–4277 CrossRef CAS PubMed.\n\nA. Massi and D. Nanni, Org. Biomol. Chem., 2012, 10, 3791–3807 CAS.\n\nH. Bader, L. C. Cross, I. Heilbron and E. Jones, J. Chem. Soc., 1949, 619–623 RSC.\n\nM. Lo Conte, S. Pacifico, A. Chambery, A. Marra and A. Dondoni, J. Org. Chem., 2010, 75, 4644–4647 CrossRef CAS PubMed.\n\nM. L. Conte, S. Staderini, A. Marra, M. Sanchez-Navarro, B. G. Davis and A. Dondoni, Chem. Commun., 2011, 47, 11086–11088 RSC.\n\nM. W. Crankshaw and G. A. Grant, Curr. Protein Pept. Sci., 2001 Search PubMed , ch. 15. unit 15.1.\n\nM. L. Anson, J. Gen. Physiol., 1940, 23, 321–331 CrossRef CAS.\n\nG. L. Ellman, Arch. Biochem. Biophys., 1959, 82, 70–77 CrossRef CAS.\n\nG. L. Kenyon and T. W. Bruice, Methods Enzymol., 1977, 47, 407–430 CAS.\n\nA. Fontana, E. Scoffone and C. A. Benassi, Biochemistry, 1968, 7, 980–986 CrossRef CAS.\n\nT. P. King, Y. Li and L. Kochoumian, Biochemistry, 1978, 17, 1499–1506 CrossRef CAS.\n\nW. M. Macindoe, A. H. van Oijen and G.-J. Boons, Chem. Commun., 1998, 847–848 RSC.\n\nB. G. Davis, M. A. Maughan, M. P. Green, A. Ullman and J. B. Jones, Tetrahedron: Asymmetry, 2000, 11, 245–262 CrossRef CAS.\n\nD. P. Gamblin, P. Garnier, S. J. Ward, N. J. Oldham, A. J. Fairbanks and B. G. Davis, Org. Biomol. Chem., 2003, 1, 3642 CAS.\n\nB. G. Davis, Macromolecules, 2002, 102, 579–602 CAS.\n\nY. J. Zhao, Y. Q. Zhai, Z. G. Su and G. H. Ma, Polym. Adv. Technol., 2010, 21, 867–873 CrossRef CAS PubMed.\n\nD. P. Gamblin, P. Garnier, S. van Kasteren, N. J. Oldham, A. J. Fairbanks and B. G. Davis, Angew. Chem., Int. Ed., 2004, 116, 846–851 CrossRef PubMed.\n\nG. J. L. Bernardes, D. P. Gamblin and B. G. Davis, Angew. Chem., Int. Ed., 2006, 118, 4111–4115 CrossRef PubMed.\n\nG. J. L. Bernardes, J. P. Marston, A. S. Batsanov, J. A. K. Howard and B. G. Davis, Chem. Commun., 2007, 3145–3147 RSC.\n\nM. Steiner, I. Hartmann, E. Perrino, G. Casi, S. Brighton, I. Jelesarov, G. J. Bernardes and D. Neri, Chem. Sci., 2013, 4, 297–302 RSC.\n\nM. Kunstelj, K. Fidler, S. Skrajnar, M. Kenig, V. Smilović, M. Kusterle, S. Caserman, I. Zore, V. G. Porekar and S. Jevševar, Bioconjugate Chem., 2013, 24, 889–896 CrossRef CAS PubMed.\n\nG. J. L. Bernardes, E. J. Grayson, S. Thompson, J. M. Chalker, J. C. Errey, F. El Oualid, T. D. W. Claridge and B. G. Davis, Angew. Chem., Int. Ed., 2008, 47, 2244–2247 CrossRef CAS PubMed.\n\nK. Whiteman, C. Audette and S. D. Wilhelm, Bioconjugate Chem., 2009, 21, 84–92 Search PubMed.\n\nM. S. Rosendahl, D. H. Doherty, D. J. Smith, S. J. Carlson, E. A. Chlipala and G. N. Cox, Bioconjugate Chem., 2005, 16, 200–207 CrossRef CAS PubMed.\n\nM. T. Petersen, P. H. Jonson and S. B. Petersen, Protein Eng., 1999, 12, 535–548 CrossRef CAS PubMed.\n\nH. J. Leung, G. Xu, M. Narayan and H. A. Scheraga, J. Pept. Res., 2005, 65, 47–54 CrossRef CAS PubMed.\n\nT. Arakawa, S. J. Prestrelski, L. O. Narhi, T. C. Boone and W. C. Kenney, J. Protein Chem., 1993, 12, 525–531 CrossRef CAS.\n\nS. Brocchini, S. Balan, A. Godwin, J.-W. Choi, M. Zloh and S. Shaunak, Nat. Protoc., 2006, 1, 2241–2252 CrossRef CAS PubMed.\n\nJ. M. Thornton, J. Mol. Biol., 1981, 151, 261–287 CrossRef CAS.\n\nR. Bhattacharyya, D. Pal and P. Chakrabarti, Protein Eng., 2004, 17, 795–808 CrossRef CAS PubMed.\n\nS. Shaunak, A. Godwin, J.-W. Choi, S. Balan, E. Pedone, D. Vijayarangam, S. Heidelberger, I. Teo, M. Zloh and S. Brocchini, Nat. Chem. Biol., 2006, 2, 312–313 CrossRef CAS PubMed.\n\nS. Balan, J.-W. Choi, A. Godwin, I. Teo, C. M. Laborde, S. Heidelberger, M. Zloh, S. Shaunak and S. Brocchini, Bioconjugate Chem., 2007, 18, 61–76 CrossRef CAS PubMed.\n\nS. Brocchini, A. Godwin, S. Balan, J.-W. Choi, M. Zloh and S. Shaunak, Adv. Drug Delivery Rev., 2008, 60, 3–12 CrossRef CAS PubMed.\n\nH. Khalili, A. Godwin, J.-W. Choi, R. Lever and S. Brocchini, Bioconjugate Chem., 2012, 23, 2262–2277 CrossRef CAS PubMed.\n\nA. Lewis, Y. Tang, S. Brocchini, J.-W. Choi and A. Godwin, Bioconjugate Chem., 2008, 19, 2144–2155 CrossRef CAS PubMed.\n\nL. Castañeda, Z. V. F. Wright, C. Marculescu, T. M. Tran, V. Chudasama, A. Maruani, E. A. Hull, J. P. M. Nunes, R. J. Fitzmaurice, M. E. B. Smith, L. H. Jones, S. Caddick and J. R. Baker, Tetrahedron Lett., 2013, 54, 3493–3495 CrossRef PubMed.\n\nM. W. Jones, R. A. Strickland, F. F. Schumacher, S. Caddick, J. R. Baker, M. I. Gibson and D. M. Haddleton, J. Am. Chem. Soc., 2012, 134, 1847–1852 CrossRef CAS PubMed.\n\nF. F. Schumacher, V. A. Sanchania, B. Tolner, Z. V. F. Wright, C. P. Ryan, M. E. B. Smith, J. M. Ward, S. Caddick, C. W. M. Kay, G. Aeppli, K. A. Chester and J. R. Baker, Sci. Rep., 2013, 3, 1–8 Search PubMed.\n\nM. E. B. Smith, J. Baker, F. F. Schumacher, S. Caddick, V. Chudasama and A. Maruani, WO2013132268, 2013, http://patentscope.wipo.int/search/en/detail.jsf?docId=WO2013132268.\n\nF. F. Schumacher, M. Nobles, C. P. Ryan, M. E. Smith, A. Tinker, S. Caddick and J. R. Baker, Bioconjugate Chem., 2011, 22, 132–136 CrossRef CAS PubMed.\n\nM. W. Jones, R. A. Strickland, F. F. Schumacher, S. Caddick, J. R. Baker, M. I. Gibson and D. M. Haddleton, Chem. Commun., 2012, 48, 4064–4066 RSC.\n\nJ. Collins, J. Tanaka, P. Wilson, K. Kempe, T. P. Davis, M. P. McIntosh, M. R. Whittaker and D. M. Haddleton, Bioconjugate Chem., 2015, 26, 633–638 CrossRef CAS PubMed.\n\nV. Chudasama, M. E. B. Smith, F. F. Schumacher, D. Papaioannou, G. Waksman, J. R. Baker and S. Caddick, Chem. Commun., 2011, 47, 8781–8783 RSC.\n\nA. Maruani, M. E. B. Smith, E. Miranda, K. A. Chester, V. Chudasama and S. Caddick, Nat. Commun., 2015, 6, 6645 CrossRef CAS PubMed.\n\nM. J. Tucker, J. R. Courter, J. Chen, O. Atasoylu, A. B. Smith and R. M. Hochstrasser, Angew. Chem., Int. Ed., 2010, 49, 3612–3616 CrossRef CAS PubMed.\n\nS. P. Brown and A. B. Smith, J. Am. Chem. Soc., 2015, 137, 4034–4037 CrossRef CAS PubMed.\n\nP. Wilson, A. Anastasaki, M. R. Owen, K. Kempe, D. M. Haddleton, S. K. Mann, A. P. R. Johnston, J. F. Quinn, M. R. Whittaker, P. J. Hogg and T. P. Davis, J. Am. Chem. Soc., 2015, 137, 4215–4222 CrossRef CAS PubMed.\n\nC. J. Chapman, K. J. Wadsworth and C. G. Frost, J. Organomet. Chem., 2003, 680, 206–211 CrossRef CAS.\n\nC. J. Chapman, A. Matsuno, C. G. Frost and M. C. Willis, Chem. Commun., 2007, 3903–3905 RSC.\n\nC. J. Chapman, J. D. Hargrave, G. Bish and C. G. Frost, Tetrahedron, 2008, 64, 9528–9539 CrossRef CAS PubMed.\n\nL. Navarre, R. Martinez, J.-P. Genet and S. Darses, J. Am. Chem. Soc., 2008, 130, 6159–6169 CrossRef CAS PubMed.\n\nG. J. L. Bernardes, J. M. Chalker, J. C. Errey and B. G. Davis, J. Am. Chem. Soc., 2008, 130, 5052–5053 CrossRef CAS PubMed.\n\nJ. M. Chalker, L. Lercher, N. R. Rose, C. J. Schofield and B. G. Davis, Angew. Chem., Int. Ed., 2012, 124, 1871–1875 CrossRef PubMed.\n\nP. N. Collier, A. D. Campbell, I. Patel and R. J. K. Taylor, Tetrahedron Lett., 2000, 41, 7115–7119 CrossRef CAS.\n\nJ. M. Chalker, S. B. Gunnoo, O. Boutureira, S. C. Gerstberger, M. Fernández-González, G. J. L. Bernardes, L. Griffin, H. Hailu, C. J. Schofield and B. G. Davis, Chem. Sci., 2011, 2, 1666–1676 RSC.\n\nI. Photaki, J. Am. Chem. Soc., 1963, 85, 1123–1126 CrossRef CAS.\n\nD. H. Strumeyer, W. N. White and D. E. Koshland, Proc. Natl. Acad. Sci. U. S. A., 1963, 50, 931–935 CrossRef CAS.\n\nH. Weiner, W. N. White, D. G. Hoare and D. E. Koshland, J. Am. Chem. Soc., 1966, 88, 3851–3859 CrossRef CAS.\n\nD. H. Rich, J. Tam, P. Mathiaparanam, J. A. Grant and C. Mabuni, J. Chem. Soc., Chem. Commun., 1974, 897–898 RSC.\n\nJ. Chalker, G. Bernardes, Y. Lin and B. Davis, Chem. – Asian J., 2009, 4, 630–640 CrossRef CAS PubMed.\n\nT. J. Holmes and R. G. Lawton, J. Am. Chem. Soc., 1977, 99, 1984–1986 CrossRef CAS.\n\nF. C. Rowan, M. Richards, R. A. Bibby, A. Thompson, R. Bayliss and J. Blagg, ACS Chem. Biol., 2013, 8, 2184–2191 CrossRef CAS PubMed.\n\nR. I. Nathani, P. Moody, V. Chudasama, M. E. B. Smith, R. J. Fitzmaurice and S. Caddick, Chem. Sci., 2013, 4, 3455–3458 RSC.\n\nK. Hashimoto, M. Sakai, T. Okuno and H. Shirahama, Chem. Commun., 1996, 1139–1140 RSC.\n\nN. M. Okeley, Y. Zhu and W. A. van der Donk, Org. Lett., 2000, 2, 3603–3606 CrossRef CAS PubMed.\n\nF. P. Seebeck and J. W. Szostak, J. Am. Chem. Soc., 2006, 128, 7150–7151 CrossRef CAS PubMed.\n\nJ. Wang, S. M. Schiller and P. G. Schultz, Angew. Chem., Int. Ed., 2007, 119, 6973–6975 CrossRef PubMed.\n\nJ. Guo, J. Wang, J. S. Lee and P. G. Schultz, Angew. Chem., Int. Ed., 2008, 120, 6499–6501 CrossRef PubMed.\n\nY. O. You, M. R. Levengood, L. A. F. Ihnken, A. K. Knowlton and W. A. van der Donk, ACS Chem. Biol., 2009, 4, 379–385 CrossRef CAS PubMed.\n\nY. A. Lin, O. Boutureira and L. Lercher, J. Am. Chem. Soc., 2013, 135, 12156–12159 CrossRef CAS PubMed.\n\nH. Lindley, Nature, 1956, 178, 647–648 CrossRef CAS PubMed.\n\nM. A. Raftery and R. D. Cole, J. Biol. Chem., 1966, 241, 3457–3461 CAS.\n\nM. D. Simon, F. Chu, L. R. Racki, C. C. de la Cruz, A. L. Burlingame, B. Panning, G. J. Narlikar and K. M. Shokat, Cell, 2007, 128, 1003–1012 CrossRef CAS PubMed.\n\nA. M. Spokoyny, Y. Zou, J. J. Ling, H. Yu, Y.-S. Lin and B. L. Pentelute, J. Am. Chem. Soc., 2013, 135, 5946–5949 CrossRef CAS PubMed.\n\nC. Zhang, A. M. Spokoyny, Y. Zou, M. D. Simon and B. L. Pentelute, Angew. Chem., Int. Ed., 2013, 52, 1–6 CrossRef PubMed.\n\nN. Toda, S. Asano and C. F. Barbas III, Angew. Chem., Int. Ed., 2013, 52, 12592–12596 CrossRef CAS PubMed.\n\nH.-Y. Shiu, T.-C. Chan, C.-M. Ho, Y. Liu, M.-K. Wong and C.-M. Che, Chem. – Eur. J., 2009, 15, 3839–3850 CrossRef CAS PubMed.\n\nC. Heinis, T. Rutherford, S. Freund and G. Winter, Nat. Chem. Biol., 2009, 5, 502–507 CrossRef CAS PubMed.\n\nS. Chen, J. Touati and C. Heinis, Chem. Commun., 2014, 50, 5267–5269 RSC.\n\nA. O.-Y. Chan, J. L.-L. Tsai, V. K.-Y. Lo, G.-L. Li, M.-K. Wong and C.-M. Che, Chem. Commun., 2013, 49, 1428–1430 RSC.\n\nP. D. Halphen and T. C. Owen, J. Org. Chem., 1973, 38, 3507–3510 CrossRef CAS.\n\nW. E. Truce and G. J. W. Tichenor, J. Org. Chem., 1972, 37, 2391–2396 CrossRef CAS.\n\nO. De Lucchi, V. Lucchini, C. Marchioro, G. Valle and G. Modena, J. Org. Chem., 1986, 51, 1457–1466 CrossRef CAS.\n\nM. Journet, A. Rouillard, D. Cai and R. D. Larsen, J. Org. Chem., 1997, 62, 8630–8631 CrossRef CAS.\n\nO. Arjona, R. Medel, J. Rojas, A. M. Costa and J. Vilarrasa, Tetrahedron Lett., 2003, 44, 6369–6373 CrossRef CAS.\n\nB. A. Trofimov, A. G. Mal'kina, O. A. Shemyakina, V. V. Nosyreva, A. P. Borisova, S. S. Khutsishvili and L. B. Krivdin, Synthesis, 2009, 3136–3142 CrossRef CAS PubMed.\n\nH.-Y. Shiu, H.-C. Chong, Y.-C. Leung, M.-K. Wong and C.-M. Che, Chem. – Eur. J., 2010, 16, 3308–3313 CrossRef CAS PubMed.\n\nO. Koniev, G. Leriche, M. Nothisen, J.-S. Remy, J.-M. Strub, C. Schaeffer-Reiss, A. Van Dorsselaer, R. Baati and A. Wagner, Bioconjugate Chem., 2014, 25, 202–206 CrossRef CAS PubMed.\n\nS. Kolodych, O. Koniev, Z. Baatarkhuu, J.-Y. Bonnefoy, F. Debaene, S. Cianférani, A. Van Dorsselaer and A. Wagner, Bioconjugate Chem., 2015, 26, 197–200 CrossRef CAS PubMed.\n\nV. Hong, A. A. Kislukhin and M. G. Finn, J. Am. Chem. Soc., 2009, 131, 9986–9994 CrossRef CAS PubMed.\n\nS. Dziadek, S. Jacques and D. R. Bundle, Chemistry, 2008, 14, 5908–5917 CrossRef CAS PubMed.\n\nM. W. Jones, G. Mantovani, S. M. Ryan, X. Wang, D. J. Brayden and D. M. Haddleton, Chem. Commun., 2009, 5272–5274 RSC.\n\nC. Haase and O. Seitz, Justus Liebigs Ann. Chem., 2009, 2096–2101 CAS.\n\nF. K. Hansen, K. Ha, E. Todadze, A. Lillicotch, A. Frey and A. R. Katritzky, Org. Biomol. Chem., 2011, 9, 7162–7167 CAS.\n\nK. Ha, M. Chahar, J.-C. M. Monbaliu, E. Todadze, F. K. Hansen, A. A. Oliferenko, C. E. Ocampo, D. Leino, A. Lillicotch, C. V. Stevens and A. R. Katritzky, J. Org. Chem., 2012, 77, 2637–2648 CrossRef CAS PubMed.\n\nO. Bol'shakov, J. Kovacs, M. Chahar, K. Ha, L. Khelashvili and A. R. Katritzky, J. Pept. Sci., 2012, 18, 704–709 CrossRef PubMed.\n\nS. S. Panda, C. El-Nachef, K. Bajaj, A. O. Al-Youbi, A. Oliferenko and A. R. Katritzky, Chem. Biol. Drug Des., 2012, 80, 821–827 CAS.\n\nJ.-C. M. Monbaliu, G. Dive, C. V. Stevens and A. R. Katritzky, J. Chem. Theory Comput., 2013, 9, 927–934 CrossRef CAS.\n\nK. Gevaert, P. Van Damme, L. Martens and J. Vandekerckhove, Anal. Biochem., 2005, 345, 18–29 CrossRef CAS PubMed.\n\nD. E. Koshland, Y. D. Karkhanis and H. G. Latham, J. Am. Chem. Soc., 1964, 86, 1448–1450 CrossRef CAS.\n\nW. E. Savige and A. Fontana, Methods Enzymol., 1977, 47, 442–453 CAS.\n\nJ. E. Bell, F. J. Castellino, I. P. Trayer and R. L. Hill, J. Biol. Chem., 1975, 250, 7579–7585 CAS.\n\nH. R. Horton and D. E. Koshland, J. Am. Chem. Soc., 1965, 87, 1126–1132 CrossRef CAS.\n\nM. Strohalm, J. Šantrůček, R. Hynek and M. Kodíček, Biochem. Biophys. Res. Commun., 2004, 323, 1134–1138 CrossRef CAS PubMed.\n\nH. J. Teuber, O. Glosauer and U. Hochmuth, Eur. J. Inorg. Chem., 1964, 557–562 CAS.\n\nA. Foettinger, M. Melmer, A. Leitner and W. Lindner, Bioconjugate Chem., 2007, 18, 1678–1683 CrossRef CAS PubMed.\n\nM. Källberg, H. Wang, S. Wang, J. Peng, Z. Wang, H. Lu and J. Xu, Nat. Protoc., 2012, 7, 1511–1522 CrossRef PubMed.\n\nA. Foettinger, A. Leitner and W. Lindner, J. Mass Spectrom., 2006, 41, 623–632 CrossRef CAS PubMed.\n\nA. Foettinger, A. Leitner and W. Lindner, J. Proteome Res., 2007, 6, 3827–3834 CrossRef CAS PubMed.\n\nJ. Antos and M. Francis, J. Am. Chem. Soc., 2004, 126, 10256–10257 CrossRef CAS PubMed.\n\nT. Ye and M. A. McKervey, Macromolecules, 1994, 94, 1091–1160 CAS.\n\nJ. M. Antos, J. M. McFarland, A. T. Iavarone and M. B. Francis, J. Am. Chem. Soc., 2009, 131, 6301–6308 CrossRef CAS PubMed.\n\nJ. M. Antos and M. B. Francis, J. Am. Chem. Soc., 2004, 126, 10256–10257 CrossRef CAS PubMed.\n\nB. V. Popp and Z. T. Ball, J. Am. Chem. Soc., 2010, 132, 6660–6662 CrossRef CAS PubMed.\n\nD. N. Woolfson, Adv. Protein Chem., 2005, 70, 79–112 CAS.\n\nZ. Chen, B. V. Popp, C. L. Bovet and Z. T. Ball, ACS Chem. Biol., 2011, 6, 920–925 CrossRef CAS PubMed.\n\nJ. L. Howland, The Encyclopedia of Molecular Biology, Biochemical Education, 1995 Search PubMed.\n\nS. Li and M. Hong, J. Am. Chem. Soc., 2011, 133, 1534–1544 CrossRef CAS PubMed.\n\nX. Li, H. Ma, S. Dong, X. Duan and S. Liang, Talanta, 2004, 62, 367–371 CrossRef CAS PubMed.\n\nX. Li, H. Ma, L. Nie, M. Sun and S. Xiong, Anal. Chim. Acta, 2004, 515, 255–260 CrossRef CAS PubMed.\n\nR. E. Parker and N. S. Isaacs, Chem. Rev., 1959, 59, 737–799 CrossRef CAS.\n\nY. Takaoka, H. Tsutsumi, N. Kasagi, E. Nakata and I. Hamachi, J. Am. Chem. Soc., 2006, 128, 3273–3280 CrossRef CAS PubMed.\n\nH. Wakabayashi, M. Miyagawa, Y. Koshi, Y. Takaoka, S. Tsukiji and I. Hamachi, Chem. – Asian J., 2008, 3, 1134–1139 CrossRef CAS PubMed.\n\nN. Miyaura and A. Suzuki, Macromolecules, 1995, 95, 2457–2483 CAS.\n\nM. Meldal and C. W. Tornøe, Macromolecules, 2008, 108, 2952–3015 CAS.\n\nJ. Z. Hearon, J. Natl. Cancer Inst., 1948, 9, 1–11 CAS.\n\nX. Wang, J. Jia, Z. Huang, M. Zhou and H. Fei, Chem. – Eur. J., 2011, 17, 8028–8032 CrossRef CAS PubMed.\n\nD.-L. Ma, W.-L. Wong, W.-H. Chung, F.-Y. Chan, P.-K. So, T.-S. Lai, Z.-Y. Zhou, Y.-C. Leung and K.-Y. Wong, Angew. Chem., Int. Ed., 2008, 47, 3735–3739 CrossRef CAS PubMed.\n\nK. Uchida and E. R. Stadtman, Proc. Natl. Acad. Sci. U. S. A., 1992, 89, 4544–4548 CrossRef CAS.\n\nR. Zamora, M. Alaiz and F. J. Hidalgo, Chem. Res. Toxicol., 1999, 12, 654–660 CrossRef CAS PubMed.\n\nF. J. Hidalgo and R. Zamora, J. Biol. Chem., 1993, 268, 16190–16197 CAS.\n\nR. Chand Bollineni, M. Fedorova and R. Hoffmann, Analyst, 2013, 138, 5081–5088 RSC.\n\nD. Wylie, M. Voloch, S. Lee, Y. H. Liu, S. Cannon Carlson, C. Cutler and B. Pramanik, Pharm. Res., 2001, 18, 1354–1360 CrossRef CAS.\n\nT. Nishino, V. Massey and C. H. Williams, J. Biol. Chem., 1980, 255, 3610–3616 CAS.\n\nE. B. Williams, S. Krishnaswamy and K. G. Mann, J. Biol. Chem., 1989, 264, 7536–7545 CAS.\n\nR. G. Fruchter and A. M. Crestfield, J. Biol. Chem., 1967, 242, 5807–5812 CAS.\n\nM. C. Lin, W. H. Stein and S. Moore, J. Biol. Chem., 1968, 243, 6167–6170 CAS.\n\nT. T. Inagami and H. H. Hatano, J. Biol. Chem., 1969, 244, 1176–1182 CAS.\n\nT. Y. Liu, J. Biol. Chem., 1967, 242, 4029–4032 CAS.\n\nH. Pauly, Hoppe-Seyler's Z. Physiol. Chem., 1905, 159–160 CrossRef CAS PubMed.\n\nH. Pauly, Hoppe-Seyler's Z. Physiol. Chem., 1915, 94, 284–290 CrossRef CAS PubMed.\n\nF. Zaheer and B. H. Nicholson, Biochim. Biophys. Acta, Protein Struct., 1971, 251, 38–43 CrossRef CAS.\n\nP. Dominici, B. Tancini and C. Borri Voltattorni, J. Biol. Chem., 1985, 260, 10583–10589 CAS.\n\nF. Marks, U. Klingmüller and K. Müller-Decker, Cellular signal processing: an introduction to the molecular mechanisms of signal transduction, lavoisier.eu, 2009 Search PubMed.\n\nM. A. Lemmon and J. Schlessinger, Cell, 2010, 141, 1117–1134 CrossRef CAS PubMed.\n\nY. Koshi, E. Nakata, M. Miyagawa, S. Tsukiji, T. Ogawa and I. Hamachi, J. Am. Chem. Soc., 2008, 130, 245–251 CrossRef CAS PubMed.\n\nS. Håkansson, J. Viljanen and K. S. Broo, Biochemistry, 2003, 42, 10260–10268 CrossRef PubMed.\n\nT. Shirai, Y. Matsui, C. Shionyu-Mitsuyama, T. Yamane, H. Kamiya, C. Ishii, T. Ogawa and K. Muramoto, J. Mol. Biol., 2002, 321, 879–889 CrossRef CAS.\n\nJ. F. Riordan, M. Sokolovsky and B. L. Vallee, J. Am. Chem. Soc., 1966, 88, 4104–4105 CrossRef CAS.\n\nK. Jiao, S. Mandapati, P. L. Skipper, S. R. Tannenbaum and J. S. Wishnok, Anal. Biochem., 2001, 293, 43–52 CrossRef CAS PubMed.\n\nH. Neurath and R. A. Kenner, Biochemistry, 1971, 10, 551–557 CrossRef CAS.\n\nG. Nikov, V. Bhat, J. S. Wishnok and S. R. Tannenbaum, Anal. Biochem., 2003, 320, 214–222 CrossRef CAS.\n\nM. Kai, J. Ishida and Y. Ohkura, J. Chromatogr. B, Biomed. Appl., 1988, 430, 271–278 CrossRef CAS.\n\nJ. Ishida, M. Kai and Y. Ohkura, J. Chromatogr. A, 1986, 356, 171–177 CrossRef CAS.\n\nB. M. Trost and F. D. Toste, J. Am. Chem. Soc., 1998, 120, 9074–9075 CrossRef CAS.\n\nB. M. Trost and F. D. Toste, J. Am. Chem. Soc., 1998, 120, 815–816 CrossRef CAS.\n\nS. Tilley and M. Francis, J. Am. Chem. Soc., 2006, 128, 1080–1081 CrossRef CAS PubMed.\n\nK. C. Brown, S.-H. Yang and T. Kodadek, Biochemistry, 1995, 34, 4733–4739 CrossRef CAS.\n\nK. C. Brown, Z. Yu, A. L. Burlingame and C. S. Craik, Biochemistry, 1998, 37, 4397–4406 CrossRef CAS PubMed.\n\nD. A. Fancy, K. Melcher, S. A. Johnston and T. Kodadek, Chem. Biol., 1996, 3, 551–559 CrossRef CAS.\n\nD. A. Fancy and T. Kodadek, Tetrahedron, 1997, 53, 11953–11960 CrossRef CAS.\n\nG. Gill, A. A. Richter-Rusli, M. Ghosh, C. J. Burrows and S. E. Rokita, Chem. Res. Toxicol., 1997, 10, 302–309 CrossRef CAS PubMed.\n\nK. Kim, D. A. Fancy, D. Carney and T. Kodadek, J. Am. Chem. Soc., 1999, 121, 11896–11897 CrossRef CAS.\n\nD. A. Fancy and T. Kodadek, Proc. Natl. Acad. Sci. U. S. A., 1999, 96, 6020–6024 CrossRef CAS.\n\nD. A. Fancy, C. Denison, K. Kim, Y. Xie, T. Holdeman, F. Amini and T. Kodadek, Chem. Biol., 2000, 7, 697–708 CrossRef CAS.\n\nM. D. Person, K. C. Brown, S. Mahrus, C. S. Craik and A. L. Burlingame, Protein Sci., 2009, 10, 1549–1562 CrossRef PubMed.\n\nT. Kodadek, I. Duroux-Richard and J. Bonnafous, Trends Pharmacol. Sci., 2005, 26, 210–217 CrossRef CAS PubMed.\n\nJ. Antos and M. Francis, Curr. Opin. Chem. Biol., 2006, 10, 253–262 CrossRef CAS PubMed.\n\nK. L. Seim, A. C. Obermeyer and M. B. Francis, J. Am. Chem. Soc., 2011, 133, 16970–16976 CrossRef CAS PubMed.\n\nI. Duroux-Richard, P. Vassault, G. Subra, J.-F. Guichou, E. Richard, B. Mouillac, C. Barberis, J. Marie and J.-C. Bonnafous, Chem. Biol., 2005, 12, 15–24 CrossRef CAS PubMed.\n\nC. Denison, J. Proteome Res., 2004, 3, 417–425 CrossRef CAS.\n\nS. Meunier, E. Strable and M. G. Finn, Chem. Biol., 2004, 11, 319–326 CrossRef CAS PubMed.\n\nH. G. Higgins and K. J. Harrington, Arch. Biochem. Biophys., 1959, 85, 409–425 CrossRef CAS.\n\nA. Roglans, A. Pla-Quintana and M. Moreno-Mañas, Chem. Rev., 2006, 106, 4622–4643 CrossRef CAS PubMed.\n\nJ. M. Hooker, E. W. Kovacs and M. B. Francis, J. Am. Chem. Soc., 2004, 126, 3718–3719 CrossRef CAS PubMed.\n\nJ. M. Hooker, A. Datta, M. Botta, K. N. Raymond and M. B. Francis, Nano Lett., 2007, 7, 2207–2210 CrossRef CAS PubMed.\n\nT. L. Schlick, Z. Ding, E. W. Kovacs and M. B. Francis, J. Am. Chem. Soc., 2005, 127, 3718–3723 CrossRef CAS PubMed.\n\nM. W. Jones, G. Mantovani, C. A. Blindauer, S. M. Ryan, X. Wang, D. J. Brayden and D. M. Haddleton, J. Am. Chem. Soc., 2012, 134, 7406–7413 CrossRef CAS PubMed.\n\nJ. Gavrilyuk, H. Ban, M. Nagano, W. Hakamata and C. F. Barbas, Bi"
    }
}